{"gene":"NFATC3","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":1996,"finding":"Calcium signaling induces a physical association between NF-AT4 (NFATC3) and calcineurin, and these molecules are transported as a complex to the nucleus, where calcineurin continues to dephosphorylate NF-AT4, counteracting a nuclear NF-AT kinase.","method":"Co-immunoprecipitation, nuclear import assays, pharmacological inhibition with cyclosporin A/FK506","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP and direct nuclear transport assays, replicated across multiple labs subsequently","pmids":["8684469"],"is_preprint":false},{"year":1997,"finding":"JNK phosphorylates NFAT4 (NFATC3) on two sites; mutational removal of these JNK phosphorylation sites causes constitutive nuclear localization of NFAT4, while JNK activation in calcineurin-stimulated cells causes nuclear exclusion of NFAT4, showing JNK opposes calcineurin-driven nuclear accumulation.","method":"In vitro kinase assay, site-directed mutagenesis, nuclear localization assays","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro phosphorylation plus mutagenesis of phosphorylation sites with direct nuclear localization readout","pmids":["9374467"],"is_preprint":false},{"year":1998,"finding":"Casein kinase I alpha (CKIα) directly binds and phosphorylates NF-AT4 (NFATC3), establishing intramolecular masking of the nuclear localization signal to inhibit nuclear translocation; MEKK1 indirectly suppresses nuclear import by stabilizing the NF-AT4/CKIα interaction.","method":"Co-immunoprecipitation, in vitro kinase assay, nuclear translocation assays, epistasis by co-expression","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct binding demonstrated by co-IP, phosphorylation by in vitro kinase assay, functional consequence (nuclear import inhibition) validated","pmids":["9630228"],"is_preprint":false},{"year":1995,"finding":"NFATc3 (NFATx) binds NFAT sites in the IL-2 promoter when combined with AP-1 (c-Fos/c-Jun) and activates IL-2 promoter transcription; it undergoes a calcium-dependent decrease in apparent molecular mass that is inhibited by FK506, consistent with calcineurin-dependent dephosphorylation.","method":"EMSA, reporter gene assay in COS-7 cells, Western blot mobility shift upon calcium elevation","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay plus mobility shift, single lab but multiple methods","pmids":["7739550"],"is_preprint":false},{"year":1995,"finding":"NFATc3 activates NFAT-site-dependent transcription and exhibits a distinct DNA-binding site specificity compared to other NFATc family members, and undergoes calcium-dependent modifications blocked by FK506.","method":"Reporter gene assay, DNA-binding specificity assays, Western blot","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional transcription assays plus binding specificity, single lab","pmids":["7650004"],"is_preprint":false},{"year":2000,"finding":"Calcineurin enzymatic activity is transiently increased during initiation of myogenic differentiation in C2C12 cells and is associated with NFATc3 nuclear translocation; adenoviral calcineurin enhances differentiation while calcineurin inhibitory peptides attenuate it; NFATc3 cotransfection enhances MyoD-directed myogenesis.","method":"Calcineurin enzymatic assay, adenoviral gene transfer, nuclear translocation assay, MyoD co-transfection","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (enzymatic assay, adenoviral rescue, co-transfection) in single study with clear functional readout","pmids":["10938134"],"is_preprint":false},{"year":2002,"finding":"Targeted disruption of NFATc3 (but not NFATc4) significantly reduces calcineurin transgene-induced cardiac hypertrophy and attenuates pressure overload- and angiotensin II-induced cardiac hypertrophy, providing genetic evidence that calcineurin signaling requires NFATc3 as a downstream effector in vivo.","method":"Genetic knockout mice, cardiac hypertrophy models (calcineurin transgene, pressure overload, angiotensin II infusion), morphometric analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic KO with multiple orthogonal hypertrophic stimuli and replicated by multiple labs subsequently","pmids":["12370307"],"is_preprint":false},{"year":2004,"finding":"NFATc3 is an obligatory component of the calcineurin-dependent signaling cascade mediating angiotensin II-induced reduction of Kv2.1 K+ channel subunit expression and decreased Kv currents in arterial smooth muscle.","method":"NFATc3 knockout mice, electrophysiology (Kv current recordings), Western blot, pharmacological inhibition","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with electrophysiology and protein expression, replicated by subsequent studies","pmids":["15322114"],"is_preprint":false},{"year":2004,"finding":"NFATc3 is required for post-myocardial infarction reductions in Kv currents (Ito, IKslow1, IKslow2) and Kv1.5, Kv2.1, Kv4.2, Kv4.3 expression; beta-adrenergic signaling activates calcineurin/NFATc3 to decrease these channels, and Kv currents do not change after MI in NFATc3 knockout mice.","method":"NFATc3 knockout mice, electrophysiology, Western blot, RT-PCR, calcineurin inhibitor (cyclosporine), beta-blocker treatment","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with multiple orthogonal methods (electrophysiology, molecular, pharmacological)","pmids":["15087419"],"is_preprint":false},{"year":2006,"finding":"NFATc3 activation down-regulates the beta1 subunit of BK channels in arterial smooth muscle during angiotensin II-induced hypertension; beta1 expression was decreased in WT but not NFATc3-null arteries, and NFATc3-null mice showed attenuated angiotensin II-induced hypertension.","method":"NFATc3 knockout mice, patch-clamp electrophysiology, Western blot, angiotensin II infusion model","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with electrophysiology and protein expression, replicated in subsequent papers","pmids":["17148444"],"is_preprint":false},{"year":2006,"finding":"Differential calcineurin/NFATc3 activity (higher in endocardial than epicardial myocytes) contributes to the transmural Ito gradient in the mouse left ventricle; NFATc3-null mice show complete loss of Ito and Kv4 heterogeneity.","method":"NFATc3 knockout mice, electrophysiology, NFAT reporter assay, Ca2+ imaging","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with electrophysiology and reporter assay, confirms prior findings","pmids":["16614306"],"is_preprint":false},{"year":2007,"finding":"NFATc3 mediates chronic hypoxia-induced pulmonary arterial remodeling; NFATc3 knockout mice do not show increased alpha-actin levels or increased arterial wall thickness after chronic hypoxia, establishing NFATc3 as required for hypoxia-induced vascular remodeling.","method":"NFATc3 knockout mice, NFAT-luciferase reporter mice, immunofluorescence, cyclosporin A pharmacology","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with reporter mice and pharmacological validation","pmids":["17403661"],"is_preprint":false},{"year":2007,"finding":"GSK-3β suppresses myogenic differentiation through negative regulation of NFATc3 nuclear translocation and transcriptional activity; NFATc3-deficient myoblasts fail to show increased muscle gene expression following GSK-3β inhibition, establishing NFATc3 as the required downstream effector.","method":"GSK-3β knockout/kinase-dead mutant reconstitution, NFATc3 knockout myoblasts, nuclear translocation assay, NFAT promoter reporter, muscle gene expression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — kinase-dead mutant rescue combined with NFATc3 KO epistasis and reporter assay","pmids":["17977834"],"is_preprint":false},{"year":2009,"finding":"NFATc3 directly activates miR-23a expression through transcriptional machinery in cardiomyocytes undergoing hypertrophy; miR-23a in turn suppresses translation of MuRF1 (muscle specific ring finger protein 1), an anti-hypertrophic protein.","method":"Reporter gene assay (miR-23a promoter), ChIP, knockdown experiments, Western blot","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assay in single lab, two orthogonal methods","pmids":["19574461"],"is_preprint":false},{"year":2010,"finding":"NFATc3 binds to the promoter region of myocardin and transcriptionally activates its expression; knockdown of myocardin attenuates hypertrophic responses triggered by NFATc3, placing myocardin downstream of NFATc3 in the hypertrophic cascade.","method":"ChIP, promoter reporter assay, siRNA knockdown, Western blot","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assay, single lab with two orthogonal methods","pmids":["20177053"],"is_preprint":false},{"year":2001,"finding":"Calcineurin/NFATc3 signaling is required for normal vasculogenesis; mice with disruption of both NFATc3 and NFATc4 die around E11 with generalized vascular assembly defects, and a Ca2+-insensitive calcineurin B mutation phenocopies these defects.","method":"Genetic double knockout mice, calcineurin B point mutation knockin, embryological analysis","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic double KO and calcineurin point mutant, multiple orthogonal genetic approaches","pmids":["11439183"],"is_preprint":false},{"year":2001,"finding":"PDGF-induced NFAT4 (NFATC3) translocation in native smooth muscle requires Ca2+ entry through voltage-dependent Ca2+ channels; elevation of [Ca2+]i by membrane depolarization or ionomycin alone is insufficient for NFAT4 nuclear accumulation, indicating Ca2+ influx is necessary but not sufficient and PDGF-induced modulation of nuclear import/export is also required.","method":"GFP-NFAT4 nuclear translocation assay, Ca2+ channel blockers, K+ channel opener, calcineurin blockers (CsA, FK506), luciferase reporter","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct nuclear localization imaging with pharmacological dissection, single lab","pmids":["11278965"],"is_preprint":false},{"year":2002,"finding":"NFAT4 (NFATC3) induces chondrogenesis and activates BMP2 gene expression; calcineurin/NFAT4 acts upstream of BMP signaling, since BMP antagonists block calcium/calcineurin-induced chondrogenesis.","method":"Calcium ionophore treatment, calcineurin inhibitor (cyclosporin A), dominant-negative BMP receptors, reporter gene assay, chondrogenic differentiation assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis via dominant-negative BMP receptor plus reporter assay, single lab","pmids":["12239209"],"is_preprint":false},{"year":2003,"finding":"Physiological intravascular pressure (100 mmHg) induces NFATc3 nuclear localization in mouse cerebral artery smooth muscle via a pathway requiring endothelial NO, cGMP-dependent kinase (PKG), voltage-dependent Ca2+ channels, and PKG-dependent inhibition of JNK2; NFATc3 nuclear accumulation is absent in JNK2-null arteries when PKG is blocked.","method":"NFATc3 immunofluorescence in intact arteries, endothelial denudation, pharmacological inhibitors (NOS, PKG, VDCC, JNK), JNK2 knockout mice","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic (JNK2 KO) plus multiple pharmacological inhibitors with direct nuclear localization readout","pmids":["14688253"],"is_preprint":false},{"year":2002,"finding":"CK1 (protein kinase CK1) phosphorylates the A domain of NF-AT4 (NFATC3) via a two-phase hierarchical mechanism: an acidic linker region provides a docking site for CK1 and allows initial (unorthodox) phosphorylation of Ser177; once phosphorylated, Ser177 primes hierarchical phosphorylation of downstream serines (S180, S181, S184, S186).","method":"In vitro kinase assay with 27 peptide variants, site-directed mutagenesis (alanine and phosphoserine substitutions), Km/Vmax analysis","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic in vitro kinase assay with mutagenesis panel defining mechanism","pmids":["11781102"],"is_preprint":false},{"year":2001,"finding":"A calcineurin-binding motif in NFATx (NFATC3) identified; a competing peptide (Pep3) based on this motif selectively blocks nuclear translocation of NFATx but not NFATp, and suppresses cytokine production by T cells expressing NFATx.","method":"Peptide competition assay, retrovirus-mediated gene transfer, nuclear translocation assay, cytokine measurement","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct competition and nuclear translocation assay, single lab with functional cytokine readout","pmids":["11509611"],"is_preprint":false},{"year":2008,"finding":"PKCα-dependent persistent Ca2+ sparklets in arterial myocytes activate the calcineurin/NFATc3 signaling cascade, leading to increased Ca2+ entry, elevated arterial [Ca2+]i, and enhanced myogenic tone during hypertension; PKCα ablation is protective against angiotensin II-induced hypertension.","method":"Total internal reflection fluorescence microscopy (Ca2+ sparklet imaging), PKCα knockout mice, NFATc3 reporter assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with live imaging and reporter assay, multiple orthogonal methods","pmids":["18832165"],"is_preprint":false},{"year":2008,"finding":"NFATc3 regulates BK channel alpha-subunit expression in urinary bladder smooth muscle; NFATc3-null mice show reduced BK currents, decreased BK alpha-subunit mRNA, and elevated contractile responses to electrical field stimulation.","method":"NFATc3 knockout mice, patch-clamp electrophysiology, RT-PCR, contractility assay","journal":"American journal of physiology. Cell physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with electrophysiology and molecular analysis, multiple readouts","pmids":["18579799"],"is_preprint":false},{"year":2009,"finding":"NFATc3 is required for chronic hypoxia-induced upregulation of soluble guanylyl cyclase alpha1 (sGC-α1) expression in pulmonary arterial smooth muscle; NFATc3 binds functional sites in the sGC-α1 promoter and activates its transcription.","method":"NFATc3 knockout mice, cyclosporin-treated mice, promoter reporter assay, NFAT binding site identification","journal":"American journal of physiology. Lung cellular and molecular physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with promoter reporter, single lab","pmids":["19592461"],"is_preprint":false},{"year":2011,"finding":"Endothelin-1 (ET-1) contributes to chronic hypoxia-induced NFATc3 activation in pulmonary arteries via RhoA/Rho kinase (ROK) and calcineurin; ROK increases actin polymerization to provide structural support for NFATc3 nuclear transport, downstream of Ca2+-calcineurin-dependent dephosphorylation.","method":"NFAT-luciferase reporter mice, pharmacological inhibitors (ET receptor, calcineurin, L-type Ca2+ channels, ROK), GFP-NFATc3 nuclear import assay in human PASMC","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay combined with live-cell imaging and pharmacological dissection, single lab","pmids":["21525433"],"is_preprint":false},{"year":2011,"finding":"NFATc3 is specifically required for IL-2 and COX-2 gene expression in T cells and for T-cell proliferation; NFATc3 also regulates COX-2 in endothelial cells where it is required for COX-2-dependent migration and angiogenesis in vivo.","method":"siRNA knockdown, reporter gene assay, cell migration assay, in vivo angiogenesis assay","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown with multiple functional readouts, single lab","pmids":["21642596"],"is_preprint":false},{"year":2011,"finding":"NFATc3 directly binds to the RANKL promoter and stimulates RANKL expression in osteoblasts in response to high extracellular calcium; NFATc1 acts upstream by inducing NFATc3 expression and activity.","method":"ChIP, reporter assay, siRNA knockdown, overexpression","journal":"Bone","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assay with siRNA knockdown, single lab","pmids":["21514407"],"is_preprint":false},{"year":2012,"finding":"In neurons, NFATc3 undergoes rapid dephosphorylation and nuclear translocation (complete within 20 min) upon Ca2+ elevation, while NFATc4 requires prolonged depolarization; the serine-proline repeat region of NFATc3 is critical for the magnitude of nuclear accumulation; knockdown of NFATc3 strongly diminishes NFAT-mediated transcription induced by mild depolarization.","method":"GFP-NFAT chimera nuclear translocation assay, NFATc3/c4 siRNA knockdown, phosphorylation immunoblot, luciferase reporter, domain-swap chimeras","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — chimera domain mapping combined with siRNA knockdown and reporter assay, single lab","pmids":["22977251"],"is_preprint":false},{"year":2012,"finding":"NFATc3 is expressed in pancreatic acinar cells and regulates trypsinogen activation and inflammatory cytokine (CXCL2) expression; NFATc3-deficient mice are protected from taurocholate- and L-arginine-induced acute pancreatitis.","method":"NFATc3 knockout mice, NFAT-luciferase reporter mice, NFAT inhibitor (A-285222), confocal immunofluorescence, trypsin activity assay","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO validated in two pancreatitis models with pharmacological inhibitor convergence","pmids":["22841788"],"is_preprint":false},{"year":2013,"finding":"NFATc3 binds to the RANTES promoter and directly regulates RANTES gene transcription in rheumatoid arthritis synovial fibroblasts in response to ASIC1a-mediated Ca2+ influx.","method":"ChIP-qPCR, dual-luciferase reporter assay, calcium imaging, ASIC1a overexpression/knockdown","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assay with Ca2+ influx manipulation, single lab","pmids":["31903118"],"is_preprint":false},{"year":2014,"finding":"Trim17 binds preferentially SUMOylated forms of NFATc3 and reduces its calcium-mediated nuclear localization by approximately 2-fold without promoting its ubiquitination/degradation; NFATc3 induces transcription of the proapoptotic gene Trim17 via binding to its promoter together with c-Jun, creating a feedback loop.","method":"Co-immunoprecipitation, luciferase reporter, nuclear translocation assay, ChIP, siRNA knockdown, neuronal apoptosis assay","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, ChIP, and reporter assay in single lab with multiple orthogonal methods","pmids":["25215946"],"is_preprint":false},{"year":2014,"finding":"T. gondii dense granule protein GRA6 selectively activates NFAT4 (NFATC3) via CAMLG (calcium modulating ligand); GRA6-deficient parasites fail to activate NFAT4, and NFAT4-deficient mice show decreased chemokine (Cxcl2, Ccl2) expression and altered immune cell recruitment at infection sites.","method":"GFP-NFAT4 reporter assay, GRA6 knockout parasites, NFAT4 knockout mice, overexpression, NFAT inhibitor treatment","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO parasite and host KO mice with mechanistic intermediate (CAMLG) identified","pmids":["25225460"],"is_preprint":false},{"year":2015,"finding":"NFATc3 inhibits miR-324-5p expression; miR-324-5p suppresses translation of Mtfr1 (mitochondrial fission regulator 1); knockdown of NFATc3 suppresses mitochondrial fission, cardiomyocyte apoptosis and myocardial infarction.","method":"ChIP, luciferase reporter, siRNA knockdown, mitochondrial morphology imaging, apoptosis assays","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assay with siRNA knockdown, single lab","pmids":["26633713"],"is_preprint":false},{"year":2016,"finding":"NFATC3 specifically binds to IRF7 protein and enhances IRF7-mediated type I IFN production; NFATC3 knockout greatly reduces CpG DNA-induced nuclear translocation of IRF7; both NFATC3 and IRF7 bind to type I IFN promoters and the NFAT binding site in IFN promoters is required for IRF7-mediated IFN expression.","method":"Co-immunoprecipitation, NFATC3 knockout (in vitro and in vivo), ChIP, reporter gene assay, NFAT binding site mutagenesis","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO combined with Co-IP, ChIP, and promoter mutagenesis","pmids":["27697837"],"is_preprint":false},{"year":2016,"finding":"ASIC1-mediated Ca2+ influx promotes NFATc3 nuclear import in pulmonary arterial smooth muscle cells via a PICK1 scaffold protein that interacts with both ASIC1 and calcineurin; PICK1 inhibition abolishes NFATc3 nuclear import without altering Ca2+ responses.","method":"ASIC1 knockout mice, pharmacological ASIC1 inhibition, Duolink proximity ligation assay, PICK1 inhibitor, GFP-NFATc3 nuclear import assay","journal":"American journal of physiology. Lung cellular and molecular physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO combined with proximity ligation assay and pharmacological dissection with live-cell imaging","pmids":["27190058"],"is_preprint":false},{"year":2017,"finding":"NFATc3 directly targets the Etv2 promoter via an evolutionarily conserved cis-element to drive hematopoietic fate commitment in embryonic stem cells; constitutively active NFATc3 rescues Etv2 expression and hematopoietic progenitor formation in IP3R-triple-knockout cells.","method":"IP3R triple-knockout embryonic stem cells, constitutively active NFATc3 overexpression rescue, ChIP showing NFATc3 binding to Etv2 promoter, NFAT reporter assay","journal":"Journal of molecular cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP with genetic rescue, single lab","pmids":["28419336"],"is_preprint":false},{"year":2019,"finding":"NFATc3 is SUMOylated; hypoxia-induced SENP3-mediated deSUMOylation of NFATc3 at K384 impairs the interaction between NFATc3 and GSK-3β, decreases NFATc3 phosphorylation, and increases NFATc3 nuclear occupancy to promote pancreatic carcinoma progression.","method":"SUMOylation site mutation (K384), co-immunoprecipitation, SENP3 knockdown, nuclear fractionation, in vitro deSUMOylation","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — site-specific mutagenesis with Co-IP and knockdown, single lab","pmids":["35484132"],"is_preprint":false},{"year":2019,"finding":"CHIP (carboxyl-terminus of Hsc70-interacting protein, an E3 ubiquitin ligase) promotes proteasomal degradation of NFATc3; co-immunoprecipitation demonstrates physical interaction between CHIP and NFATc3, and CHIP overexpression reduces NFATc3 protein levels and attenuates hypertrophy and apoptosis.","method":"Co-immunoprecipitation, Western blot, proteasome inhibitor treatment, CHIP overexpression","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single Co-IP with functional overexpression data, single lab","pmids":["30980393"],"is_preprint":false},{"year":2020,"finding":"NFATc3 transcriptionally upregulates miR-204 in macrophages; miR-204-5p suppresses SR-A expression via canonical 3'UTR targeting, while nuclear miR-204-3p inhibits CD36 transcription; this NFATc3/miR-204 axis prevents foam cell formation and atherosclerosis.","method":"Macrophage-specific NFATc3 knockout and transgenic mice, ChIP, miR-204 rescue experiments, luciferase reporter","journal":"European heart journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — tissue-specific genetic KO and transgenic mice with ChIP and rescue experiments","pmids":["34570211"],"is_preprint":false},{"year":2020,"finding":"NFATc3 activates miR-153-3p expression in cardiomyocytes; ChIP-qPCR and luciferase reporter assay confirmed NFATc3 as upstream transcriptional regulator of miR-153-3p; miR-153-3p suppresses Mfn1 translation, promoting mitochondrial fission and hypertrophy.","method":"ChIP-qPCR, luciferase reporter assay, siRNA knockdown, mitochondrial morphology imaging","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assay, single lab","pmids":["31903137"],"is_preprint":false},{"year":2021,"finding":"NFATc3 binds to the promoters of IFNL1 and IFNB1 genes in hepatocytes to promote IFN production; RIG-I pathway activation increases NFATc3 nuclear localization, which further enhances RIG-I-mediated IFN responses (positive feedback).","method":"ChIP, reporter gene assay, gain- and loss-of-function experiments, nuclear localization assay","journal":"Oncoimmunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP with reporter assay and gain/loss of function, single lab","pmids":["33520407"],"is_preprint":false},{"year":2022,"finding":"Trim39 is an E3 ubiquitin ligase for NFATc3 that acts preferentially on SUMOylated forms of NFATc3; Trim39 binds and ubiquitinates NFATc3 in vitro and in cells, reducing NFATc3 protein level and transcriptional activity; Trim17 inhibits Trim39-mediated ubiquitination of NFATc3 by reducing both Trim39 E3 activity and the NFATc3/Trim39 interaction.","method":"In vitro ubiquitination assay, co-immunoprecipitation, siRNA knockdown, luciferase reporter, SUMOylation site mutagenesis, SUMO-interacting motif mutagenesis","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro ubiquitination assay plus mutagenesis and Co-IP, replicated with cellular assays","pmids":["35449213"],"is_preprint":false},{"year":2013,"finding":"NFATc3 promotes Ca2+-dependent MMP3 expression in astrocytes; constitutively active NFATc3 induces Mmp3 expression, and a Mmp3 promoter luciferase reporter is activated by increased [Ca2+]i via calcineurin/NFAT, while other MMPs are unaffected.","method":"Constitutively active NFATc3 overexpression, calcium ionophore, cyclosporin A inhibition, promoter reporter assay, in vivo stab-wound model","journal":"Glia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay with pharmacological and genetic activation, in vivo validation","pmids":["23625833"],"is_preprint":false},{"year":2013,"finding":"NFATc3 binds to the -GGAAA- sequence in the COX-2 promoter and transcriptionally activates COX-2 expression in cardiomyocytes in response to endothelin-1, as demonstrated by ChIP and promoter reporter assay.","method":"ChIP, promoter reporter assay, NFATc3 knockdown, cyclosporin A","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP with reporter assay, single lab","pmids":["24291639"],"is_preprint":false},{"year":2014,"finding":"Nuclear Raf-1 phosphorylated at Ser621 associates with NFATc3 near its cognate binding site in the CXCR5 promoter, driving transcriptional upregulation of CXCR5 during retinoic acid-induced differentiation of HL-60 leukemic cells.","method":"Co-immunoprecipitation, ChIP, pharmacological inhibition (PD98059), reporter assay","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and ChIP with functional inhibitor validation, single lab","pmids":["24330068"],"is_preprint":false},{"year":2021,"finding":"NFATc3 regulates CXCL2 gene expression in macrophages (CXCL2 promoter-luciferase reporter activity is accentuated by co-transfection with NFATc3 expression vector); NFATc3-deficient macrophages fail to produce CCL2 and CXCL2 in response to IL-33 or conditioned medium from bleomycin-treated epithelial cells, and adoptive transfer of NFATc3+/+ macrophages restores susceptibility to pulmonary fibrosis in NFATc3+/- mice.","method":"Promoter-luciferase reporter assay, macrophage-specific conditional KO, adoptive transfer, in vitro cytokine stimulation","journal":"Aging and disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay with genetic KO and adoptive transfer, single lab","pmids":["37523510"],"is_preprint":false},{"year":2017,"finding":"NFATc3 occupies the RAG1 promoter for transcriptional repression; NFATc3 knockdown increases RAG1 expression and double-strand DNA damage in gastric cancer cells, while NFATc3 overexpression blocks RAG1 expression and DNA damage induced by arsenic sulfide.","method":"ChIP-qPCR, RNA-seq, siRNA knockdown, lentiviral overexpression, Western blot","journal":"Journal of experimental & clinical cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP with gain and loss of function, single lab","pmids":["31822296"],"is_preprint":false},{"year":2019,"finding":"NFATc3 binds to the OCT4 promoter and activates OCT4 transcription to promote cancer stem cell self-renewal in oral squamous cell carcinoma; inhibition of OCT4 abrogates the CSC phenotype driven by NFATc3.","method":"ChIP, promoter reporter assay, NFATc3 overexpression and knockdown, OCT4 rescue experiments, tumor sphere formation assay","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP with promoter reporter and epistasis rescue, single lab","pmids":["31040921"],"is_preprint":false},{"year":2017,"finding":"NFATc3 promotes myocardin (and AQP2) promoter activity; NFATc3 knockout mice display symptoms of nephrogenic diabetes insipidus (polyuria, reduced AQP2 expression) and ILK-conditional-knockdown mice show reduced nuclear localization of NFATc3, linking ILK→GSK3β→NFATc3 to AQP2 transcription.","method":"NFATc3 knockout mice, ILK conditional knockdown, reporter gene assay, nuclear localization assay","journal":"Biochimica et biophysica acta. Gene regulatory mechanisms","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with reporter assay, single lab","pmids":["28736155"],"is_preprint":false},{"year":2021,"finding":"NFATc3 interacts with c-JUN and regulates the expression of SRPX2; SRPX2 knockdown diminishes the upregulation of lineage and EMT markers induced by co-overexpression of NFATc3 and c-JUN in human embryonic stem cells, placing SRPX2 downstream of the NFATc3/c-JUN complex.","method":"Co-immunoprecipitation (NFATc3/c-JUN), siRNA knockdown, overexpression, differentiation marker assays","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP with siRNA epistasis, single lab","pmids":["33393109"],"is_preprint":false},{"year":2006,"finding":"Activity-independent nucleocytoplasmic shuttling of NFATc1 occurs in resting skeletal muscle fibers (leptomycin B causes nuclear accumulation); however, NFATc3 does NOT show similar shuttling in resting fibers — leptomycin B did not cause nuclear accumulation of NFATc3 in unstimulated fibers, demonstrating isoform-specific regulation.","method":"Live-cell imaging of GFP-NFAT isoforms in adult skeletal muscle fibers, leptomycin B treatment, electrical stimulation, calcineurin inhibition","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct live imaging with pharmacological tools, negative result for NFATc3 vs positive for NFATc1 clearly demonstrated","pmids":["16436503"],"is_preprint":false}],"current_model":"NFATC3 is a calcium-dependent transcription factor that resides in a heavily phosphorylated, cytoplasmic inactive state; calcium signals promote its association with calcineurin, which dephosphorylates key serine residues (initially Ser177 via a CK1α-primed hierarchical mechanism, opposed by JNK-mediated phosphorylation) to unmask the nuclear localization signal, enabling nuclear import as a calcineurin–NFATC3 complex; in the nucleus it binds NFAT/AP-1 composite sites to drive target gene programs including Kv2.1/BK-β1 channel subunit suppression in vascular smooth muscle, miR-23a/miR-153-3p/miR-324-5p-mediated cardiac hypertrophic remodeling, COX-2 and RANKL transactivation, IRF7-dependent type I interferon production in plasmacytoid dendritic cells, and alpha-actin/sGC-α1 upregulation during pulmonary hypertension; its activity is further tuned by SUMOylation (deSUMOylation by SENP3 at K384 reduces GSK-3β-mediated phosphorylation to increase nuclear occupancy under hypoxia), by CHIP/Trim39-mediated ubiquitin-proteasomal degradation (Trim39 preferentially targets SUMOylated NFATc3, antagonized by Trim17), and by PICK1-scaffolded coupling to ASIC1-mediated Ca2+ influx for nuclear import."},"narrative":{"mechanistic_narrative":"NFATC3 is a calcium- and calcineurin-regulated transcription factor that converts intracellular Ca2+ signals into target-gene programs governing cardiovascular remodeling, vascular tone, immune signaling, and cell differentiation [PMID:8684469, PMID:12370307, PMID:15322114]. In its resting state it is held in the cytoplasm by phosphorylation: casein kinase Iα directly binds and phosphorylates the regulatory A domain through a two-phase hierarchical mechanism in which a primed Ser177 nucleates phosphorylation of downstream serines, masking the nuclear localization signal [PMID:9630228, PMID:11781102], and JNK phosphorylates additional sites that drive nuclear exclusion [PMID:9374467]. Calcium influx triggers physical association with the phosphatase calcineurin, which dephosphorylates NFATC3 and is co-transported with it into the nucleus where it counters a nuclear NFAT kinase to sustain nuclear residence [PMID:8684469]. In the nucleus NFATC3 binds NFAT sites, frequently cooperating with AP-1 partners such as c-Jun, to activate transcription with a DNA-binding specificity distinct from other family members [PMID:7739550, PMID:7650004, PMID:33393109]. Genetic deletion establishes NFATC3 as the obligatory calcineurin effector for pathological cardiac hypertrophy and for arterial smooth-muscle remodeling, where it suppresses K+ channel subunits (Kv1.5, Kv2.1, Kv4.2/4.3) and the BK channel β1 and α subunits to alter excitability and tone during hypertension and after myocardial infarction [PMID:12370307, PMID:15322114, PMID:15087419, PMID:17148444, PMID:18579799]. It drives hypoxia-induced pulmonary arterial remodeling and directly transactivates target promoters including sGC-α1, COX-2, RANKL, and myocardin, and activates miRNA programs (miR-23a, miR-153-3p, miR-324-5p, miR-204) that tune hypertrophy, mitochondrial fission, and atherogenesis [PMID:17403661, PMID:19574461, PMID:20177053, PMID:19592461, PMID:34570211, PMID:24291639]. In immunity NFATC3 binds IRF7 and type I interferon promoters to potentiate antiviral interferon production and controls chemokine output in macrophages and during pathogen infection [PMID:25225460, PMID:27697837, PMID:33520407, PMID:37523510]. Its abundance and nuclear occupancy are further set by SUMOylation, by SENP3-mediated deSUMOylation that weakens GSK-3β-dependent phosphorylation under hypoxia, and by the E3 ligases CHIP and Trim39 that drive proteasomal turnover, with Trim39 acting preferentially on SUMOylated NFATC3 and being antagonized by Trim17 [PMID:35484132, PMID:30980393, PMID:35449213].","teleology":[{"year":1995,"claim":"Establishing that NFATC3 is a genuine NFAT-family transcription factor required showing it binds NFAT DNA elements and activates transcription in a calcium-regulated manner, which it did with distinct site specificity and AP-1 cooperativity.","evidence":"EMSA, reporter assays, and calcium-dependent mobility shift in COS-7/transfected cells","pmids":["7739550","7650004"],"confidence":"Medium","gaps":["Endogenous target genes not yet defined","Mechanism of calcium-dependent mass change inferred, not directly mapped to residues"]},{"year":1996,"claim":"The core activation switch was defined by demonstrating calcium-induced physical association with calcineurin and co-transport as a complex that maintains nuclear dephosphorylation against an opposing kinase.","evidence":"Co-immunoprecipitation, nuclear import assays, cyclosporin A/FK506 inhibition","pmids":["8684469"],"confidence":"High","gaps":["Identity of the opposing nuclear kinase not resolved here","Binding interface not mapped"]},{"year":1997,"claim":"The kinase arm opposing activation was identified by showing JNK phosphorylates two sites whose mutation causes constitutive nuclear NFATC3, establishing JNK as an antagonist of calcineurin-driven import.","evidence":"In vitro kinase assay, phosphosite mutagenesis, nuclear localization readout","pmids":["9374467"],"confidence":"High","gaps":["Upstream signals controlling JNK in physiological contexts not addressed"]},{"year":1998,"claim":"How phosphorylation masks the NLS was clarified by showing CKIα directly binds and phosphorylates NFATC3 to enforce cytoplasmic retention, with MEKK1 stabilizing this interaction.","evidence":"Co-IP, in vitro kinase assay, nuclear translocation and co-expression epistasis","pmids":["9630228"],"confidence":"High","gaps":["Precise serines targeted by CKIα not yet enumerated at this stage"]},{"year":2002,"claim":"The biochemical logic of CKI control was resolved by defining a docking-and-priming hierarchical mechanism initiating at Ser177 and propagating to downstream serines.","evidence":"Systematic in vitro kinase assays on 27 peptide variants with phosphoserine/alanine mutagenesis and kinetic analysis","pmids":["11781102"],"confidence":"High","gaps":["In vivo occupancy of each site under physiological signaling not quantified"]},{"year":2001,"claim":"Physiological relevance of the calcineurin/NFAT axis was established genetically by showing NFATC3/NFATC4 double knockouts die with vascular assembly defects phenocopied by a Ca2+-insensitive calcineurin mutation.","evidence":"Double knockout and calcineurin B point-mutant knockin mice, embryological analysis","pmids":["11439183"],"confidence":"High","gaps":["NFATC3-specific versus redundant contribution within the double KO not separated"]},{"year":2002,"claim":"Cell-type-specific input requirements were defined by showing PDGF-induced nuclear import in smooth muscle needs Ca2+ entry through voltage-dependent channels plus PDGF-driven modulation, indicating Ca2+ alone is insufficient.","evidence":"GFP-NFAT4 imaging with Ca2+/K+ channel and calcineurin pharmacology","pmids":["11278965"],"confidence":"Medium","gaps":["The additional PDGF-dependent step controlling import/export not molecularly identified"]},{"year":2002,"claim":"NFATC3 was shown to be the required calcineurin effector for pathological cardiac hypertrophy across multiple stimuli, distinguishing it from NFATC4.","evidence":"Knockout mice in calcineurin-transgene, pressure-overload, and angiotensin II hypertrophy models","pmids":["12370307"],"confidence":"High","gaps":["Direct hypertrophic target genes not yet identified in this study"]},{"year":2008,"claim":"A coherent vascular program emerged from knockout studies showing NFATC3 mediates calcineurin-dependent suppression of Kv and BK channel subunits to control arterial and bladder smooth-muscle excitability and tone.","evidence":"NFATC3 knockout mice with patch-clamp electrophysiology, Western blot/RT-PCR, hypertension and contractility models","pmids":["15322114","15087419","17148444","16614306","18579799","18832165"],"confidence":"High","gaps":["Whether channel suppression is via direct promoter binding or indirect intermediates not fully resolved for each target"]},{"year":2009,"claim":"The pulmonary remodeling branch was mechanized by showing NFATC3 is required for hypoxia-induced α-actin and sGC-α1 upregulation, with NFATC3 binding the sGC-α1 promoter, and later linked to ET-1/RhoA-ROK-supported nuclear transport.","evidence":"Knockout and NFAT-reporter mice, promoter reporter assays, pharmacology and GFP-NFATc3 imaging in PASMC","pmids":["17403661","19592461","21525433"],"confidence":"High","gaps":["Direct NFAT occupancy of the α-actin promoter not shown","ROK/actin contribution to import is correlative"]},{"year":2010,"claim":"Direct transcriptional outputs in heart and other tissues were defined by ChIP/reporter evidence placing myocardin, COX-2, RANKL, and several miRNAs downstream of NFATC3.","evidence":"ChIP, promoter reporter assays, siRNA knockdown across cardiomyocyte, osteoblast, and T/endothelial systems","pmids":["20177053","19574461","21642596","21514407","24291639","31903137","26633713"],"confidence":"Medium","gaps":["Most targets validated in single labs","Combinatorial cofactor requirements at each promoter not mapped"]},{"year":2012,"claim":"Isoform-specific kinetics were established by showing NFATC3 dephosphorylates and translocates rapidly upon mild Ca2+ signals, unlike NFATC4, with its serine-proline region controlling nuclear accumulation magnitude.","evidence":"GFP-NFAT chimera imaging, domain-swap constructs, siRNA, reporter assays in neurons; leptomycin B comparison in muscle fibers","pmids":["22977251","16436503"],"confidence":"Medium","gaps":["Structural basis for the serine-proline region effect not solved"]},{"year":2014,"claim":"An immune signaling role was defined by showing pathogen GRA6/CAMLG selectively activates NFATC3 and that NFATC3 binds IRF7 and type I IFN promoters to potentiate interferon production.","evidence":"Knockout parasites and host mice, Co-IP, ChIP, promoter mutagenesis","pmids":["25225460","27697837","33520407"],"confidence":"High","gaps":["Stoichiometry of the NFATC3-IRF7 complex on promoters not defined"]},{"year":2014,"claim":"Post-translational control of NFATC3 stability and nuclear occupancy was uncovered through SUMOylation-coupled ubiquitination: Trim17 and Trim39 act on SUMOylated NFATC3, CHIP drives proteasomal turnover, and SENP3 deSUMOylation reduces GSK-3β-dependent phosphorylation under hypoxia.","evidence":"Co-IP, in vitro ubiquitination, SUMO/SIM mutagenesis, SENP3 knockdown, ChIP and reporter assays","pmids":["25215946","35449213","30980393","35484132"],"confidence":"High","gaps":["Some interactions (e.g., CHIP) rest on single Co-IP","Crosstalk between SUMO, ubiquitin and phosphorylation not integrated quantitatively"]},{"year":2017,"claim":"Developmental and oncogenic transcriptional targets were extended by ChIP-based identification of Etv2, OCT4, RAG1, and SRPX2 as NFATC3-regulated loci controlling hematopoietic commitment, stemness, DNA damage, and differentiation.","evidence":"ChIP, promoter reporters, genetic rescue, gain/loss-of-function in stem cells and cancer lines","pmids":["28419336","31040921","31822296","33393109"],"confidence":"Medium","gaps":["Each target validated in a single cellular context","Direct repression versus activation mechanisms not uniformly defined"]},{"year":2016,"claim":"A scaffolded route for Ca2+ entry was defined by showing PICK1 couples ASIC1-mediated Ca2+ influx to calcineurin to drive NFATC3 nuclear import in pulmonary smooth muscle.","evidence":"ASIC1 knockout mice, PICK1 inhibition, proximity ligation assay, GFP-NFATc3 imaging","pmids":["27190058","31903118"],"confidence":"High","gaps":["Whether PICK1-ASIC1-calcineurin coupling operates outside vascular/synovial contexts unknown"]},{"year":null,"claim":"How the multiple post-translational inputs (CKIα/JNK/GSK-3β phosphorylation, SUMOylation, SENP3 deSUMOylation, CHIP/Trim39 ubiquitination) are integrated in real time to set NFATC3 nuclear occupancy and select among its many target programs remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No integrated kinetic model linking modifications to target-gene selection","No structural model of the calcineurin-NFATC3 or NFATC3-IRF7/c-Jun complexes","Tissue determinants of target-gene choice not defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,3,4,33,38,43]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[3,4,23,43,35]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,1,2,16,27]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,2,16]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,2,18,21]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[3,33,38,43]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[25,31,33,40,45]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[36,37,41]}],"complexes":[],"partners":["PPP3 (CALCINEURIN)","CSNK1A1","JNK","IRF7","JUN","TRIM39","TRIM17","PICK1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q12968","full_name":"Nuclear factor of activated T-cells, cytoplasmic 3","aliases":["NFATx","T-cell transcription factor NFAT4","NF-AT4","NF-AT4c"],"length_aa":1075,"mass_kda":115.6,"function":"Acts as a regulator of transcriptional activation. Binds to the TNFSF11/RANKL promoter region and promotes TNFSF11 transcription (By similarity). Binding to the TNFSF11 promoter region is increased by high levels of Ca(2+) which induce NFATC3 expression and may lead to regulation of TNFSF11 expression in osteoblasts (By similarity). Plays a role in promoting mesenteric arterial wall remodeling in response to the intermittent hypoxia-induced increase in EDN1 and ROCK signaling (By similarity). As a result NFATC3 colocalizes with F-actin filaments, translocates to the nucleus and promotes transcription of the smooth muscle hypertrophy and differentiation marker ACTA2 (By similarity). Promotes lipopolysaccharide-induced apoptosis and hypertrophy in cardiomyocytes (By similarity). Following JAK/STAT signaling activation and as part of a complex with NFATC4 and STAT3, binds to the alpha-beta E4 promoter region of CRYAB and activates transcription in cardiomyocytes (By similarity). In conjunction with NFATC4, involved in embryonic heart development via maintenance of cardiomyocyte survival, proliferation and differentiation (By similarity). Plays a role in the inducible expression of cytokine genes in T-cells, especially in the induction of the IL-2 (PubMed:18815128). Required for thymocyte maturation during DN3 to DN4 transition and during positive selection (By similarity). Positively regulates macrophage-derived polymicrobial clearance, via binding to the promoter region and promoting transcription of NOS2 resulting in subsequent generation of nitric oxide (By similarity). Involved in Ca(2+)-mediated transcriptional responses upon Ca(2+) influx via ORAI1 CRAC channels","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q12968/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NFATC3","classification":"Not Classified","n_dependent_lines":21,"n_total_lines":1208,"dependency_fraction":0.0173841059602649},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NFATC3","total_profiled":1310},"omim":[{"mim_id":"617514","title":"IMMUNODEFICIENCY 52; IMD52","url":"https://www.omim.org/entry/617514"},{"mim_id":"609618","title":"NONCODING REPRESSOR OF NFAT; NRON","url":"https://www.omim.org/entry/609618"},{"mim_id":"607962","title":"MICRO RNA 23A; MIR23A","url":"https://www.omim.org/entry/607962"},{"mim_id":"606131","title":"TRIPARTITE MOTIF-CONTAINING PROTEIN 63; TRIM63","url":"https://www.omim.org/entry/606131"},{"mim_id":"602699","title":"NUCLEAR FACTOR OF ACTIVATED T CELLS, CYTOPLASMIC, CALCINEURIN-DEPENDENT 4; NFATC4","url":"https://www.omim.org/entry/602699"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":95.0}],"url":"https://www.proteinatlas.org/search/NFATC3"},"hgnc":{"alias_symbol":["NFAT4","NFATX","n339260"],"prev_symbol":[]},"alphafold":{"accession":"Q12968","domains":[{"cath_id":"2.60.40.340","chopping":"410-589","consensus_level":"high","plddt":92.1588,"start":410,"end":589},{"cath_id":"2.60.40.10","chopping":"600-697","consensus_level":"high","plddt":93.0836,"start":600,"end":697}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q12968","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q12968-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q12968-F1-predicted_aligned_error_v6.png","plddt_mean":54.34},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NFATC3","jax_strain_url":"https://www.jax.org/strain/search?query=NFATC3"},"sequence":{"accession":"Q12968","fasta_url":"https://rest.uniprot.org/uniprotkb/Q12968.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q12968/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q12968"}},"corpus_meta":[{"pmid":"8684469","id":"PMC_8684469","title":"Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4.","date":"1996","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8684469","citation_count":434,"is_preprint":false},{"pmid":"11439183","id":"PMC_11439183","title":"Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature.","date":"2001","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/11439183","citation_count":352,"is_preprint":false},{"pmid":"19574461","id":"PMC_19574461","title":"miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19574461","citation_count":303,"is_preprint":false},{"pmid":"9374467","id":"PMC_9374467","title":"Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway.","date":"1997","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9374467","citation_count":299,"is_preprint":false},{"pmid":"9630228","id":"PMC_9630228","title":"Intramolecular masking of nuclear import signal on NF-AT4 by casein kinase I and MEKK1.","date":"1998","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/9630228","citation_count":267,"is_preprint":false},{"pmid":"10938134","id":"PMC_10938134","title":"A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10938134","citation_count":240,"is_preprint":false},{"pmid":"12370307","id":"PMC_12370307","title":"Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12370307","citation_count":218,"is_preprint":false},{"pmid":"9768749","id":"PMC_9768749","title":"The transcription factor NFAT4 is involved in the generation and survival of T cells.","date":"1998","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/9768749","citation_count":210,"is_preprint":false},{"pmid":"7739550","id":"PMC_7739550","title":"NFATx, a novel member of the nuclear factor of activated T cells family that is expressed predominantly in the thymus.","date":"1995","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7739550","citation_count":208,"is_preprint":false},{"pmid":"7650004","id":"PMC_7650004","title":"NFATc3, a lymphoid-specific NFATc family member that is calcium-regulated and exhibits distinct DNA binding specificity.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7650004","citation_count":161,"is_preprint":false},{"pmid":"20177053","id":"PMC_20177053","title":"miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20177053","citation_count":136,"is_preprint":false},{"pmid":"12750314","id":"PMC_12750314","title":"NFATc3 and NFATc4 are required for cardiac development and mitochondrial function.","date":"2003","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/12750314","citation_count":122,"is_preprint":false},{"pmid":"11740499","id":"PMC_11740499","title":"NFATc2 and NFATc3 regulate T(H)2 differentiation and modulate TCR-responsiveness of naïve T(H)cells.","date":"2001","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11740499","citation_count":115,"is_preprint":false},{"pmid":"15657288","id":"PMC_15657288","title":"NFATc2 and NFATc3 transcription factors play a crucial role in suppression of CD4+ T lymphocytes by CD4+ CD25+ regulatory T cells.","date":"2005","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15657288","citation_count":115,"is_preprint":false},{"pmid":"18832165","id":"PMC_18832165","title":"The control of Ca2+ influx and NFATc3 signaling in arterial smooth muscle during hypertension.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18832165","citation_count":105,"is_preprint":false},{"pmid":"17148444","id":"PMC_17148444","title":"Activation of NFATc3 down-regulates the beta1 subunit of large conductance, calcium-activated K+ channels in arterial smooth muscle and contributes to hypertension.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17148444","citation_count":103,"is_preprint":false},{"pmid":"11278965","id":"PMC_11278965","title":"NFAT4 movement in native smooth muscle. A role for differential Ca(2+) signaling.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11278965","citation_count":100,"is_preprint":false},{"pmid":"34570211","id":"PMC_34570211","title":"Macrophage NFATc3 prevents foam cell formation and atherosclerosis: evidence and mechanisms.","date":"2021","source":"European heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/34570211","citation_count":96,"is_preprint":false},{"pmid":"25225460","id":"PMC_25225460","title":"Selective and strain-specific NFAT4 activation by the Toxoplasma gondii polymorphic dense granule protein GRA6.","date":"2014","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25225460","citation_count":93,"is_preprint":false},{"pmid":"15322114","id":"PMC_15322114","title":"NFATc3 regulates Kv2.1 expression in arterial smooth muscle.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15322114","citation_count":93,"is_preprint":false},{"pmid":"17403661","id":"PMC_17403661","title":"NFATc3 mediates chronic hypoxia-induced pulmonary arterial remodeling with alpha-actin up-regulation.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17403661","citation_count":93,"is_preprint":false},{"pmid":"15087419","id":"PMC_15087419","title":"NFATc3-induced reductions in voltage-gated K+ currents after myocardial infarction.","date":"2004","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/15087419","citation_count":90,"is_preprint":false},{"pmid":"12239209","id":"PMC_12239209","title":"Calcineurin and NFAT4 induce chondrogenesis.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12239209","citation_count":88,"is_preprint":false},{"pmid":"16614306","id":"PMC_16614306","title":"Differential calcineurin/NFATc3 activity contributes to the Ito transmural gradient in the mouse heart.","date":"2006","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/16614306","citation_count":66,"is_preprint":false},{"pmid":"31903118","id":"PMC_31903118","title":"ASIC1a induces synovial inflammation via the Ca2+/NFATc3/ RANTES pathway.","date":"2020","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/31903118","citation_count":61,"is_preprint":false},{"pmid":"17977834","id":"PMC_17977834","title":"Glycogen synthase kinase 3 suppresses myogenic differentiation through negative regulation of NFATc3.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17977834","citation_count":58,"is_preprint":false},{"pmid":"21494433","id":"PMC_21494433","title":"Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.","date":"2011","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/21494433","citation_count":58,"is_preprint":false},{"pmid":"26633713","id":"PMC_26633713","title":"NFAT4-dependent miR-324-5p regulates mitochondrial morphology and cardiomyocyte cell death by targeting Mtfr1.","date":"2015","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/26633713","citation_count":53,"is_preprint":false},{"pmid":"22841788","id":"PMC_22841788","title":"NFATc3 regulates trypsinogen activation, neutrophil recruitment, and tissue damage in acute pancreatitis in mice.","date":"2012","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/22841788","citation_count":52,"is_preprint":false},{"pmid":"23929433","id":"PMC_23929433","title":"miR-23a inhibits E-cadherin expression and is regulated by AP-1 and NFAT4 complex during Fas-induced EMT in gastrointestinal cancer.","date":"2013","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/23929433","citation_count":51,"is_preprint":false},{"pmid":"21642596","id":"PMC_21642596","title":"NFATc3 regulates the transcription of genes involved in T-cell activation and angiogenesis.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21642596","citation_count":47,"is_preprint":false},{"pmid":"14688253","id":"PMC_14688253","title":"Intraluminal pressure is a stimulus for NFATc3 nuclear accumulation: role of calcium, endothelium-derived nitric oxide, and cGMP-dependent protein kinase.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14688253","citation_count":46,"is_preprint":false},{"pmid":"17579027","id":"PMC_17579027","title":"Selective role of NFATc3 in positive selection of thymocytes.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17579027","citation_count":45,"is_preprint":false},{"pmid":"31903137","id":"PMC_31903137","title":"NFATc3-dependent expression of miR-153-3p promotes mitochondrial fragmentation in cardiac hypertrophy by impairing mitofusin-1 expression.","date":"2020","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/31903137","citation_count":44,"is_preprint":false},{"pmid":"20967884","id":"PMC_20967884","title":"Response of transcription factor NFATc3 to excitotoxic and traumatic brain insults: identification of a subpopulation of reactive astrocytes.","date":"2010","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/20967884","citation_count":43,"is_preprint":false},{"pmid":"30022558","id":"PMC_30022558","title":"Long noncoding RNA n339260 promotes vasculogenic mimicry and cancer stem cell development in hepatocellular carcinoma.","date":"2018","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/30022558","citation_count":41,"is_preprint":false},{"pmid":"17035332","id":"PMC_17035332","title":"NFAT4 is required for JC virus infection of glial cells.","date":"2006","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/17035332","citation_count":40,"is_preprint":false},{"pmid":"16051745","id":"PMC_16051745","title":"A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus.","date":"2005","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/16051745","citation_count":40,"is_preprint":false},{"pmid":"16436503","id":"PMC_16436503","title":"Activity- and calcineurin-independent nuclear shuttling of NFATc1, but not NFATc3, in adult skeletal muscle fibers.","date":"2006","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/16436503","citation_count":38,"is_preprint":false},{"pmid":"15016802","id":"PMC_15016802","title":"The pro-hypertrophic basic helix-loop-helix protein p8 is degraded by the ubiquitin/proteasome system in a protein kinase B/Akt- and glycogen synthase kinase-3-dependent manner, whereas endothelin induction of p8 mRNA and renal mesangial cell hypertrophy require NFAT4.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15016802","citation_count":37,"is_preprint":false},{"pmid":"24975447","id":"PMC_24975447","title":"Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.","date":"2014","source":"Environmental toxicology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24975447","citation_count":37,"is_preprint":false},{"pmid":"22977251","id":"PMC_22977251","title":"Distinct activation properties of the nuclear factor of activated T-cells (NFAT) isoforms NFATc3 and NFATc4 in neurons.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22977251","citation_count":37,"is_preprint":false},{"pmid":"21525433","id":"PMC_21525433","title":"Endothelin-1 contributes to increased NFATc3 activation by chronic hypoxia in pulmonary arteries.","date":"2011","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21525433","citation_count":36,"is_preprint":false},{"pmid":"19027024","id":"PMC_19027024","title":"NFATc3-dependent loss of I(to) gradient across the left ventricular wall during chronic beta adrenergic stimulation.","date":"2008","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/19027024","citation_count":35,"is_preprint":false},{"pmid":"31005256","id":"PMC_31005256","title":"Transient receptor potential vanilloid 4 is a critical mediator in LPS mediated inflammation by mediating calcineurin/NFATc3 signaling.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31005256","citation_count":35,"is_preprint":false},{"pmid":"21514407","id":"PMC_21514407","title":"High extracellular calcium-induced NFATc3 regulates the expression of receptor activator of NF-κB ligand in osteoblasts.","date":"2011","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/21514407","citation_count":33,"is_preprint":false},{"pmid":"24239798","id":"PMC_24239798","title":"Intermittent hypoxia-induced increases in reactive oxygen species activate NFATc3 increasing endothelin-1 vasoconstrictor reactivity.","date":"2013","source":"Vascular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24239798","citation_count":33,"is_preprint":false},{"pmid":"11509611","id":"PMC_11509611","title":"Inhibition of NFATx activation by an oligopeptide: disrupting the interaction of NFATx with calcineurin.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11509611","citation_count":32,"is_preprint":false},{"pmid":"30299584","id":"PMC_30299584","title":"Activation of transient receptor potential vanilloid 3 channel (TRPV3) aggravated pathological cardiac hypertrophy via calcineurin/NFATc3 pathway in rats.","date":"2018","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30299584","citation_count":32,"is_preprint":false},{"pmid":"19592461","id":"PMC_19592461","title":"Regulation of soluble guanylyl cyclase-alpha1 expression in chronic hypoxia-induced pulmonary hypertension: role of NFATc3 and HuR.","date":"2009","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19592461","citation_count":32,"is_preprint":false},{"pmid":"26473838","id":"PMC_26473838","title":"MiR-30a Inhibits the Epithelial--Mesenchymal Transition of Podocytes through Downregulation of NFATc3.","date":"2015","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26473838","citation_count":31,"is_preprint":false},{"pmid":"31571030","id":"PMC_31571030","title":"Oleic Acid Protects from Arsenic-Induced Cardiac Hypertrophy via AMPK/FoxO/NFATc3 Pathway.","date":"2020","source":"Cardiovascular toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/31571030","citation_count":29,"is_preprint":false},{"pmid":"17881610","id":"PMC_17881610","title":"Activity-dependent NFATc3 nuclear accumulation in pericytes from cortical parenchymal microvessels.","date":"2007","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17881610","citation_count":29,"is_preprint":false},{"pmid":"12626567","id":"PMC_12626567","title":"Role of NFATx (NFAT4/NFATc3) in expression of immunoregulatory genes in murine peripheral CD4+ T cells.","date":"2003","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12626567","citation_count":28,"is_preprint":false},{"pmid":"22749879","id":"PMC_22749879","title":"Cooperative roles of NF-κB and NFAT4 in polyomavirus JC regulation at the KB control element.","date":"2012","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/22749879","citation_count":28,"is_preprint":false},{"pmid":"22846573","id":"PMC_22846573","title":"Aβ-induced Ca(2+) influx regulates astrocytic BACE1 expression via calcineurin/NFAT4 signals.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22846573","citation_count":28,"is_preprint":false},{"pmid":"25215946","id":"PMC_25215946","title":"Control of neuronal apoptosis by reciprocal regulation of NFATc3 and Trim17.","date":"2014","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/25215946","citation_count":28,"is_preprint":false},{"pmid":"20495147","id":"PMC_20495147","title":"NFATc3 contributes to intermittent hypoxia-induced arterial remodeling in mice.","date":"2010","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20495147","citation_count":27,"is_preprint":false},{"pmid":"23625833","id":"PMC_23625833","title":"NFATc3 promotes Ca(2+) -dependent MMP3 expression in astroglial cells.","date":"2013","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/23625833","citation_count":25,"is_preprint":false},{"pmid":"31249342","id":"PMC_31249342","title":"NFATc3 controls tumour growth by regulating proliferation and migration of human astroglioma cells.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31249342","citation_count":24,"is_preprint":false},{"pmid":"24291639","id":"PMC_24291639","title":"COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.","date":"2013","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/24291639","citation_count":24,"is_preprint":false},{"pmid":"33840648","id":"PMC_33840648","title":"Fusobacterium nucleatum Promotes Cisplatin-Resistance and Migration of Oral Squamous Carcinoma Cells by Up-Regulating Wnt5a-Mediated NFATc3 Expression.","date":"2021","source":"The Tohoku journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33840648","citation_count":24,"is_preprint":false},{"pmid":"24330068","id":"PMC_24330068","title":"Nuclear Raf-1 kinase regulates the CXCR5 promoter by associating with NFATc3 to drive retinoic acid-induced leukemic cell differentiation.","date":"2014","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/24330068","citation_count":24,"is_preprint":false},{"pmid":"18579799","id":"PMC_18579799","title":"NFATc3 regulates BK channel function in murine urinary bladder smooth muscle.","date":"2008","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18579799","citation_count":24,"is_preprint":false},{"pmid":"27697837","id":"PMC_27697837","title":"NFATC3 promotes IRF7 transcriptional activity in plasmacy--toid dendritic cells.","date":"2016","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27697837","citation_count":23,"is_preprint":false},{"pmid":"30895498","id":"PMC_30895498","title":"LncRNA NRON alleviates atrial fibrosis via promoting NFATc3 phosphorylation.","date":"2019","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30895498","citation_count":23,"is_preprint":false},{"pmid":"23206701","id":"PMC_23206701","title":"Positive feedback control between STIM1 and NFATc3 is required for C2C12 myoblast differentiation.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/23206701","citation_count":23,"is_preprint":false},{"pmid":"32667692","id":"PMC_32667692","title":"circNFATC3 sponges miR-548I acts as a ceRNA to protect NFATC3 itself and suppressed hepatocellular carcinoma progression.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32667692","citation_count":23,"is_preprint":false},{"pmid":"37523510","id":"PMC_37523510","title":"NFATc3 Promotes Pulmonary Inflammation and Fibrosis by Regulating Production of CCL2 and CXCL2 in Macrophages.","date":"2023","source":"Aging and disease","url":"https://pubmed.ncbi.nlm.nih.gov/37523510","citation_count":22,"is_preprint":false},{"pmid":"27190058","id":"PMC_27190058","title":"ASIC1-mediated calcium entry stimulates NFATc3 nuclear translocation via PICK1 coupling in pulmonary arterial smooth muscle cells.","date":"2016","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27190058","citation_count":22,"is_preprint":false},{"pmid":"32024440","id":"PMC_32024440","title":"The protective effect of Hederagenin on pulmonary fibrosis by regulating the Ras/JNK/NFAT4 axis in rats.","date":"2020","source":"Bioscience, biotechnology, and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32024440","citation_count":22,"is_preprint":false},{"pmid":"20369390","id":"PMC_20369390","title":"Simvastatin stimulates production of the antiapoptotic protein Bcl-2 via endothelin-1 and NFATc3 in SH-SY5Y cells.","date":"2010","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/20369390","citation_count":21,"is_preprint":false},{"pmid":"28881766","id":"PMC_28881766","title":"NFATc3 mediates the sensitivity of gastric cancer cells to arsenic sulfide.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28881766","citation_count":21,"is_preprint":false},{"pmid":"33495839","id":"PMC_33495839","title":"MicroRNA‑153 attenuates hypoxia‑induced excessive proliferation and migration of pulmonary arterial smooth muscle cells by targeting ROCK1 and NFATc3.","date":"2021","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/33495839","citation_count":21,"is_preprint":false},{"pmid":"30307161","id":"PMC_30307161","title":"NFATc3 deficiency reduces the classical activation of adipose tissue macrophages.","date":"2018","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/30307161","citation_count":20,"is_preprint":false},{"pmid":"28419336","id":"PMC_28419336","title":"IP3R-mediated Ca2+ signals govern hematopoietic and cardiac divergence of Flk1+ cells via the calcineurin-NFATc3-Etv2 pathway.","date":"2017","source":"Journal of molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28419336","citation_count":20,"is_preprint":false},{"pmid":"31040921","id":"PMC_31040921","title":"NFATc3 plays an oncogenic role in oral/oropharyngeal squamous cell carcinomas by promoting cancer stemness via expression of OCT4.","date":"2019","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/31040921","citation_count":20,"is_preprint":false},{"pmid":"33520407","id":"PMC_33520407","title":"NFATc3 inhibits hepatocarcinogenesis and HBV replication via positively regulating RIG-I-mediated interferon transcription.","date":"2021","source":"Oncoimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/33520407","citation_count":19,"is_preprint":false},{"pmid":"36257194","id":"PMC_36257194","title":"Exosomes derived from bone marrow mesenchymal stem cells inhibit human aortic vascular smooth muscle cells calcification via the miR-15a/15b/16/NFATc3/OCN axis.","date":"2022","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/36257194","citation_count":19,"is_preprint":false},{"pmid":"11781102","id":"PMC_11781102","title":"Structural features underlying the multisite phosphorylation of the A domain of the NF-AT4 transcription factor by protein kinase CK1.","date":"2002","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11781102","citation_count":19,"is_preprint":false},{"pmid":"35562351","id":"PMC_35562351","title":"TARBP2-stablized SNHG7 regulates blood-brain barrier permeability by acting as a competing endogenous RNA to miR-17-5p/NFATC3 in Aβ-microenvironment.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35562351","citation_count":18,"is_preprint":false},{"pmid":"29909608","id":"PMC_29909608","title":"NFATC3-PLA2G15 Fusion Transcript Identified by RNA Sequencing Promotes Tumor Invasion and Proliferation in Colorectal Cancer Cell Lines.","date":"2018","source":"Cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/29909608","citation_count":17,"is_preprint":false},{"pmid":"30980393","id":"PMC_30980393","title":"CHIP attenuates lipopolysaccharide-induced cardiac hypertrophy and apoptosis by promoting NFATc3 proteasomal degradation.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30980393","citation_count":17,"is_preprint":false},{"pmid":"34684485","id":"PMC_34684485","title":"Betulinic Acid Improves Cardiac-Renal Dysfunction Caused by Hypertrophy through Calcineurin-NFATc3 Signaling.","date":"2021","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/34684485","citation_count":17,"is_preprint":false},{"pmid":"35484132","id":"PMC_35484132","title":"Hypoxia-induced NFATc3 deSUMOylation enhances pancreatic carcinoma progression.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35484132","citation_count":16,"is_preprint":false},{"pmid":"28125639","id":"PMC_28125639","title":"NFATc3 and VIP in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28125639","citation_count":16,"is_preprint":false},{"pmid":"12671993","id":"PMC_12671993","title":"NFAT4 is expressed in primary astrocytes and activated by glutamate.","date":"2003","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/12671993","citation_count":16,"is_preprint":false},{"pmid":"33002827","id":"PMC_33002827","title":"Rhamnocitrin extracted from Nervilia fordii inhibited vascular endothelial activation via miR-185/STIM-1/SOCE/NFATc3.","date":"2020","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33002827","citation_count":16,"is_preprint":false},{"pmid":"11907091","id":"PMC_11907091","title":"Yin Yang 1, Oct1, and NFAT-4 form repeating, cyclosporin-sensitive regulatory modules within the murine CD21 intronic control region.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11907091","citation_count":15,"is_preprint":false},{"pmid":"11997392","id":"PMC_11997392","title":"A constitutively nuclear form of NFATx shows efficient transactivation activity and induces differentiation of CD4(+)CD8(+) T cells.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11997392","citation_count":14,"is_preprint":false},{"pmid":"36087696","id":"PMC_36087696","title":"Puerarin ameliorates myocardial remodeling of spontaneously hypertensive rats through inhibiting TRPC6-CaN-NFATc3 pathway.","date":"2022","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36087696","citation_count":13,"is_preprint":false},{"pmid":"31822296","id":"PMC_31822296","title":"Arsenic sulfide induces RAG1-dependent DNA damage for cell killing by inhibiting NFATc3 in gastric cancer cells.","date":"2019","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/31822296","citation_count":13,"is_preprint":false},{"pmid":"31030170","id":"PMC_31030170","title":"Fas/FasL-mediated cell death in rat's diabetic hearts involves activation of calcineurin/NFAT4 and is potentiated by a high-fat diet rich in corn oil.","date":"2019","source":"The Journal of nutritional biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31030170","citation_count":12,"is_preprint":false},{"pmid":"35449213","id":"PMC_35449213","title":"Trim39 regulates neuronal apoptosis by acting as a SUMO-targeted E3 ubiquitin-ligase for the transcription factor NFATc3.","date":"2022","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/35449213","citation_count":12,"is_preprint":false},{"pmid":"33886061","id":"PMC_33886061","title":"miR-145-5p targets paxillin to attenuate angiotensin II-induced pathological cardiac hypertrophy via downregulation of Rac 1, pJNK, p-c-Jun, NFATc3, ANP and by Sirt-1 upregulation.","date":"2021","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33886061","citation_count":12,"is_preprint":false},{"pmid":"29641598","id":"PMC_29641598","title":"Fasudil improves endothelial dysfunction in rats exposed to chronic intermittent hypoxia through RhoA/ROCK/NFATc3 pathway.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29641598","citation_count":12,"is_preprint":false},{"pmid":"19059606","id":"PMC_19059606","title":"NFAT4 deficiency results in incomplete liver regeneration following partial hepatectomy.","date":"2008","source":"The Journal of surgical research","url":"https://pubmed.ncbi.nlm.nih.gov/19059606","citation_count":11,"is_preprint":false},{"pmid":"28736155","id":"PMC_28736155","title":"Integrin linked kinase regulates the transcription of AQP2 by NFATC3.","date":"2017","source":"Biochimica et biophysica acta. Gene regulatory mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/28736155","citation_count":11,"is_preprint":false},{"pmid":"25422138","id":"PMC_25422138","title":"Increased expression of NF-AT3 and NF-AT4 in the atria correlates with procollagen I carboxyl terminal peptide and TGF-β1 levels in serum of patients with atrial fibrillation.","date":"2014","source":"BMC cardiovascular disorders","url":"https://pubmed.ncbi.nlm.nih.gov/25422138","citation_count":11,"is_preprint":false},{"pmid":"33393109","id":"PMC_33393109","title":"Calcineurin A gamma and NFATc3/SRPX2 axis contribute to human embryonic stem cell differentiation.","date":"2021","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33393109","citation_count":10,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52556,"output_tokens":11527,"usd":0.165287,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":22642,"output_tokens":5301,"usd":0.122868,"stage2_stop_reason":"end_turn"},"total_usd":0.288155,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"Calcium signaling induces a physical association between NF-AT4 (NFATC3) and calcineurin, and these molecules are transported as a complex to the nucleus, where calcineurin continues to dephosphorylate NF-AT4, counteracting a nuclear NF-AT kinase.\",\n      \"method\": \"Co-immunoprecipitation, nuclear import assays, pharmacological inhibition with cyclosporin A/FK506\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP and direct nuclear transport assays, replicated across multiple labs subsequently\",\n      \"pmids\": [\"8684469\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"JNK phosphorylates NFAT4 (NFATC3) on two sites; mutational removal of these JNK phosphorylation sites causes constitutive nuclear localization of NFAT4, while JNK activation in calcineurin-stimulated cells causes nuclear exclusion of NFAT4, showing JNK opposes calcineurin-driven nuclear accumulation.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis, nuclear localization assays\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro phosphorylation plus mutagenesis of phosphorylation sites with direct nuclear localization readout\",\n      \"pmids\": [\"9374467\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Casein kinase I alpha (CKIα) directly binds and phosphorylates NF-AT4 (NFATC3), establishing intramolecular masking of the nuclear localization signal to inhibit nuclear translocation; MEKK1 indirectly suppresses nuclear import by stabilizing the NF-AT4/CKIα interaction.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, nuclear translocation assays, epistasis by co-expression\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct binding demonstrated by co-IP, phosphorylation by in vitro kinase assay, functional consequence (nuclear import inhibition) validated\",\n      \"pmids\": [\"9630228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"NFATc3 (NFATx) binds NFAT sites in the IL-2 promoter when combined with AP-1 (c-Fos/c-Jun) and activates IL-2 promoter transcription; it undergoes a calcium-dependent decrease in apparent molecular mass that is inhibited by FK506, consistent with calcineurin-dependent dephosphorylation.\",\n      \"method\": \"EMSA, reporter gene assay in COS-7 cells, Western blot mobility shift upon calcium elevation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay plus mobility shift, single lab but multiple methods\",\n      \"pmids\": [\"7739550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"NFATc3 activates NFAT-site-dependent transcription and exhibits a distinct DNA-binding site specificity compared to other NFATc family members, and undergoes calcium-dependent modifications blocked by FK506.\",\n      \"method\": \"Reporter gene assay, DNA-binding specificity assays, Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional transcription assays plus binding specificity, single lab\",\n      \"pmids\": [\"7650004\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Calcineurin enzymatic activity is transiently increased during initiation of myogenic differentiation in C2C12 cells and is associated with NFATc3 nuclear translocation; adenoviral calcineurin enhances differentiation while calcineurin inhibitory peptides attenuate it; NFATc3 cotransfection enhances MyoD-directed myogenesis.\",\n      \"method\": \"Calcineurin enzymatic assay, adenoviral gene transfer, nuclear translocation assay, MyoD co-transfection\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (enzymatic assay, adenoviral rescue, co-transfection) in single study with clear functional readout\",\n      \"pmids\": [\"10938134\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Targeted disruption of NFATc3 (but not NFATc4) significantly reduces calcineurin transgene-induced cardiac hypertrophy and attenuates pressure overload- and angiotensin II-induced cardiac hypertrophy, providing genetic evidence that calcineurin signaling requires NFATc3 as a downstream effector in vivo.\",\n      \"method\": \"Genetic knockout mice, cardiac hypertrophy models (calcineurin transgene, pressure overload, angiotensin II infusion), morphometric analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic KO with multiple orthogonal hypertrophic stimuli and replicated by multiple labs subsequently\",\n      \"pmids\": [\"12370307\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"NFATc3 is an obligatory component of the calcineurin-dependent signaling cascade mediating angiotensin II-induced reduction of Kv2.1 K+ channel subunit expression and decreased Kv currents in arterial smooth muscle.\",\n      \"method\": \"NFATc3 knockout mice, electrophysiology (Kv current recordings), Western blot, pharmacological inhibition\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with electrophysiology and protein expression, replicated by subsequent studies\",\n      \"pmids\": [\"15322114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"NFATc3 is required for post-myocardial infarction reductions in Kv currents (Ito, IKslow1, IKslow2) and Kv1.5, Kv2.1, Kv4.2, Kv4.3 expression; beta-adrenergic signaling activates calcineurin/NFATc3 to decrease these channels, and Kv currents do not change after MI in NFATc3 knockout mice.\",\n      \"method\": \"NFATc3 knockout mice, electrophysiology, Western blot, RT-PCR, calcineurin inhibitor (cyclosporine), beta-blocker treatment\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with multiple orthogonal methods (electrophysiology, molecular, pharmacological)\",\n      \"pmids\": [\"15087419\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"NFATc3 activation down-regulates the beta1 subunit of BK channels in arterial smooth muscle during angiotensin II-induced hypertension; beta1 expression was decreased in WT but not NFATc3-null arteries, and NFATc3-null mice showed attenuated angiotensin II-induced hypertension.\",\n      \"method\": \"NFATc3 knockout mice, patch-clamp electrophysiology, Western blot, angiotensin II infusion model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with electrophysiology and protein expression, replicated in subsequent papers\",\n      \"pmids\": [\"17148444\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Differential calcineurin/NFATc3 activity (higher in endocardial than epicardial myocytes) contributes to the transmural Ito gradient in the mouse left ventricle; NFATc3-null mice show complete loss of Ito and Kv4 heterogeneity.\",\n      \"method\": \"NFATc3 knockout mice, electrophysiology, NFAT reporter assay, Ca2+ imaging\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with electrophysiology and reporter assay, confirms prior findings\",\n      \"pmids\": [\"16614306\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"NFATc3 mediates chronic hypoxia-induced pulmonary arterial remodeling; NFATc3 knockout mice do not show increased alpha-actin levels or increased arterial wall thickness after chronic hypoxia, establishing NFATc3 as required for hypoxia-induced vascular remodeling.\",\n      \"method\": \"NFATc3 knockout mice, NFAT-luciferase reporter mice, immunofluorescence, cyclosporin A pharmacology\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with reporter mice and pharmacological validation\",\n      \"pmids\": [\"17403661\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GSK-3β suppresses myogenic differentiation through negative regulation of NFATc3 nuclear translocation and transcriptional activity; NFATc3-deficient myoblasts fail to show increased muscle gene expression following GSK-3β inhibition, establishing NFATc3 as the required downstream effector.\",\n      \"method\": \"GSK-3β knockout/kinase-dead mutant reconstitution, NFATc3 knockout myoblasts, nuclear translocation assay, NFAT promoter reporter, muscle gene expression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — kinase-dead mutant rescue combined with NFATc3 KO epistasis and reporter assay\",\n      \"pmids\": [\"17977834\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NFATc3 directly activates miR-23a expression through transcriptional machinery in cardiomyocytes undergoing hypertrophy; miR-23a in turn suppresses translation of MuRF1 (muscle specific ring finger protein 1), an anti-hypertrophic protein.\",\n      \"method\": \"Reporter gene assay (miR-23a promoter), ChIP, knockdown experiments, Western blot\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assay in single lab, two orthogonal methods\",\n      \"pmids\": [\"19574461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"NFATc3 binds to the promoter region of myocardin and transcriptionally activates its expression; knockdown of myocardin attenuates hypertrophic responses triggered by NFATc3, placing myocardin downstream of NFATc3 in the hypertrophic cascade.\",\n      \"method\": \"ChIP, promoter reporter assay, siRNA knockdown, Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assay, single lab with two orthogonal methods\",\n      \"pmids\": [\"20177053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Calcineurin/NFATc3 signaling is required for normal vasculogenesis; mice with disruption of both NFATc3 and NFATc4 die around E11 with generalized vascular assembly defects, and a Ca2+-insensitive calcineurin B mutation phenocopies these defects.\",\n      \"method\": \"Genetic double knockout mice, calcineurin B point mutation knockin, embryological analysis\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic double KO and calcineurin point mutant, multiple orthogonal genetic approaches\",\n      \"pmids\": [\"11439183\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"PDGF-induced NFAT4 (NFATC3) translocation in native smooth muscle requires Ca2+ entry through voltage-dependent Ca2+ channels; elevation of [Ca2+]i by membrane depolarization or ionomycin alone is insufficient for NFAT4 nuclear accumulation, indicating Ca2+ influx is necessary but not sufficient and PDGF-induced modulation of nuclear import/export is also required.\",\n      \"method\": \"GFP-NFAT4 nuclear translocation assay, Ca2+ channel blockers, K+ channel opener, calcineurin blockers (CsA, FK506), luciferase reporter\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct nuclear localization imaging with pharmacological dissection, single lab\",\n      \"pmids\": [\"11278965\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"NFAT4 (NFATC3) induces chondrogenesis and activates BMP2 gene expression; calcineurin/NFAT4 acts upstream of BMP signaling, since BMP antagonists block calcium/calcineurin-induced chondrogenesis.\",\n      \"method\": \"Calcium ionophore treatment, calcineurin inhibitor (cyclosporin A), dominant-negative BMP receptors, reporter gene assay, chondrogenic differentiation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis via dominant-negative BMP receptor plus reporter assay, single lab\",\n      \"pmids\": [\"12239209\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Physiological intravascular pressure (100 mmHg) induces NFATc3 nuclear localization in mouse cerebral artery smooth muscle via a pathway requiring endothelial NO, cGMP-dependent kinase (PKG), voltage-dependent Ca2+ channels, and PKG-dependent inhibition of JNK2; NFATc3 nuclear accumulation is absent in JNK2-null arteries when PKG is blocked.\",\n      \"method\": \"NFATc3 immunofluorescence in intact arteries, endothelial denudation, pharmacological inhibitors (NOS, PKG, VDCC, JNK), JNK2 knockout mice\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic (JNK2 KO) plus multiple pharmacological inhibitors with direct nuclear localization readout\",\n      \"pmids\": [\"14688253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"CK1 (protein kinase CK1) phosphorylates the A domain of NF-AT4 (NFATC3) via a two-phase hierarchical mechanism: an acidic linker region provides a docking site for CK1 and allows initial (unorthodox) phosphorylation of Ser177; once phosphorylated, Ser177 primes hierarchical phosphorylation of downstream serines (S180, S181, S184, S186).\",\n      \"method\": \"In vitro kinase assay with 27 peptide variants, site-directed mutagenesis (alanine and phosphoserine substitutions), Km/Vmax analysis\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic in vitro kinase assay with mutagenesis panel defining mechanism\",\n      \"pmids\": [\"11781102\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"A calcineurin-binding motif in NFATx (NFATC3) identified; a competing peptide (Pep3) based on this motif selectively blocks nuclear translocation of NFATx but not NFATp, and suppresses cytokine production by T cells expressing NFATx.\",\n      \"method\": \"Peptide competition assay, retrovirus-mediated gene transfer, nuclear translocation assay, cytokine measurement\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct competition and nuclear translocation assay, single lab with functional cytokine readout\",\n      \"pmids\": [\"11509611\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PKCα-dependent persistent Ca2+ sparklets in arterial myocytes activate the calcineurin/NFATc3 signaling cascade, leading to increased Ca2+ entry, elevated arterial [Ca2+]i, and enhanced myogenic tone during hypertension; PKCα ablation is protective against angiotensin II-induced hypertension.\",\n      \"method\": \"Total internal reflection fluorescence microscopy (Ca2+ sparklet imaging), PKCα knockout mice, NFATc3 reporter assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with live imaging and reporter assay, multiple orthogonal methods\",\n      \"pmids\": [\"18832165\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NFATc3 regulates BK channel alpha-subunit expression in urinary bladder smooth muscle; NFATc3-null mice show reduced BK currents, decreased BK alpha-subunit mRNA, and elevated contractile responses to electrical field stimulation.\",\n      \"method\": \"NFATc3 knockout mice, patch-clamp electrophysiology, RT-PCR, contractility assay\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with electrophysiology and molecular analysis, multiple readouts\",\n      \"pmids\": [\"18579799\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NFATc3 is required for chronic hypoxia-induced upregulation of soluble guanylyl cyclase alpha1 (sGC-α1) expression in pulmonary arterial smooth muscle; NFATc3 binds functional sites in the sGC-α1 promoter and activates its transcription.\",\n      \"method\": \"NFATc3 knockout mice, cyclosporin-treated mice, promoter reporter assay, NFAT binding site identification\",\n      \"journal\": \"American journal of physiology. Lung cellular and molecular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with promoter reporter, single lab\",\n      \"pmids\": [\"19592461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Endothelin-1 (ET-1) contributes to chronic hypoxia-induced NFATc3 activation in pulmonary arteries via RhoA/Rho kinase (ROK) and calcineurin; ROK increases actin polymerization to provide structural support for NFATc3 nuclear transport, downstream of Ca2+-calcineurin-dependent dephosphorylation.\",\n      \"method\": \"NFAT-luciferase reporter mice, pharmacological inhibitors (ET receptor, calcineurin, L-type Ca2+ channels, ROK), GFP-NFATc3 nuclear import assay in human PASMC\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay combined with live-cell imaging and pharmacological dissection, single lab\",\n      \"pmids\": [\"21525433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NFATc3 is specifically required for IL-2 and COX-2 gene expression in T cells and for T-cell proliferation; NFATc3 also regulates COX-2 in endothelial cells where it is required for COX-2-dependent migration and angiogenesis in vivo.\",\n      \"method\": \"siRNA knockdown, reporter gene assay, cell migration assay, in vivo angiogenesis assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown with multiple functional readouts, single lab\",\n      \"pmids\": [\"21642596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NFATc3 directly binds to the RANKL promoter and stimulates RANKL expression in osteoblasts in response to high extracellular calcium; NFATc1 acts upstream by inducing NFATc3 expression and activity.\",\n      \"method\": \"ChIP, reporter assay, siRNA knockdown, overexpression\",\n      \"journal\": \"Bone\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assay with siRNA knockdown, single lab\",\n      \"pmids\": [\"21514407\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"In neurons, NFATc3 undergoes rapid dephosphorylation and nuclear translocation (complete within 20 min) upon Ca2+ elevation, while NFATc4 requires prolonged depolarization; the serine-proline repeat region of NFATc3 is critical for the magnitude of nuclear accumulation; knockdown of NFATc3 strongly diminishes NFAT-mediated transcription induced by mild depolarization.\",\n      \"method\": \"GFP-NFAT chimera nuclear translocation assay, NFATc3/c4 siRNA knockdown, phosphorylation immunoblot, luciferase reporter, domain-swap chimeras\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — chimera domain mapping combined with siRNA knockdown and reporter assay, single lab\",\n      \"pmids\": [\"22977251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NFATc3 is expressed in pancreatic acinar cells and regulates trypsinogen activation and inflammatory cytokine (CXCL2) expression; NFATc3-deficient mice are protected from taurocholate- and L-arginine-induced acute pancreatitis.\",\n      \"method\": \"NFATc3 knockout mice, NFAT-luciferase reporter mice, NFAT inhibitor (A-285222), confocal immunofluorescence, trypsin activity assay\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO validated in two pancreatitis models with pharmacological inhibitor convergence\",\n      \"pmids\": [\"22841788\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NFATc3 binds to the RANTES promoter and directly regulates RANTES gene transcription in rheumatoid arthritis synovial fibroblasts in response to ASIC1a-mediated Ca2+ influx.\",\n      \"method\": \"ChIP-qPCR, dual-luciferase reporter assay, calcium imaging, ASIC1a overexpression/knockdown\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assay with Ca2+ influx manipulation, single lab\",\n      \"pmids\": [\"31903118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Trim17 binds preferentially SUMOylated forms of NFATc3 and reduces its calcium-mediated nuclear localization by approximately 2-fold without promoting its ubiquitination/degradation; NFATc3 induces transcription of the proapoptotic gene Trim17 via binding to its promoter together with c-Jun, creating a feedback loop.\",\n      \"method\": \"Co-immunoprecipitation, luciferase reporter, nuclear translocation assay, ChIP, siRNA knockdown, neuronal apoptosis assay\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, ChIP, and reporter assay in single lab with multiple orthogonal methods\",\n      \"pmids\": [\"25215946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"T. gondii dense granule protein GRA6 selectively activates NFAT4 (NFATC3) via CAMLG (calcium modulating ligand); GRA6-deficient parasites fail to activate NFAT4, and NFAT4-deficient mice show decreased chemokine (Cxcl2, Ccl2) expression and altered immune cell recruitment at infection sites.\",\n      \"method\": \"GFP-NFAT4 reporter assay, GRA6 knockout parasites, NFAT4 knockout mice, overexpression, NFAT inhibitor treatment\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO parasite and host KO mice with mechanistic intermediate (CAMLG) identified\",\n      \"pmids\": [\"25225460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NFATc3 inhibits miR-324-5p expression; miR-324-5p suppresses translation of Mtfr1 (mitochondrial fission regulator 1); knockdown of NFATc3 suppresses mitochondrial fission, cardiomyocyte apoptosis and myocardial infarction.\",\n      \"method\": \"ChIP, luciferase reporter, siRNA knockdown, mitochondrial morphology imaging, apoptosis assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assay with siRNA knockdown, single lab\",\n      \"pmids\": [\"26633713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NFATC3 specifically binds to IRF7 protein and enhances IRF7-mediated type I IFN production; NFATC3 knockout greatly reduces CpG DNA-induced nuclear translocation of IRF7; both NFATC3 and IRF7 bind to type I IFN promoters and the NFAT binding site in IFN promoters is required for IRF7-mediated IFN expression.\",\n      \"method\": \"Co-immunoprecipitation, NFATC3 knockout (in vitro and in vivo), ChIP, reporter gene assay, NFAT binding site mutagenesis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO combined with Co-IP, ChIP, and promoter mutagenesis\",\n      \"pmids\": [\"27697837\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"ASIC1-mediated Ca2+ influx promotes NFATc3 nuclear import in pulmonary arterial smooth muscle cells via a PICK1 scaffold protein that interacts with both ASIC1 and calcineurin; PICK1 inhibition abolishes NFATc3 nuclear import without altering Ca2+ responses.\",\n      \"method\": \"ASIC1 knockout mice, pharmacological ASIC1 inhibition, Duolink proximity ligation assay, PICK1 inhibitor, GFP-NFATc3 nuclear import assay\",\n      \"journal\": \"American journal of physiology. Lung cellular and molecular physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO combined with proximity ligation assay and pharmacological dissection with live-cell imaging\",\n      \"pmids\": [\"27190058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NFATc3 directly targets the Etv2 promoter via an evolutionarily conserved cis-element to drive hematopoietic fate commitment in embryonic stem cells; constitutively active NFATc3 rescues Etv2 expression and hematopoietic progenitor formation in IP3R-triple-knockout cells.\",\n      \"method\": \"IP3R triple-knockout embryonic stem cells, constitutively active NFATc3 overexpression rescue, ChIP showing NFATc3 binding to Etv2 promoter, NFAT reporter assay\",\n      \"journal\": \"Journal of molecular cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with genetic rescue, single lab\",\n      \"pmids\": [\"28419336\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NFATc3 is SUMOylated; hypoxia-induced SENP3-mediated deSUMOylation of NFATc3 at K384 impairs the interaction between NFATc3 and GSK-3β, decreases NFATc3 phosphorylation, and increases NFATc3 nuclear occupancy to promote pancreatic carcinoma progression.\",\n      \"method\": \"SUMOylation site mutation (K384), co-immunoprecipitation, SENP3 knockdown, nuclear fractionation, in vitro deSUMOylation\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — site-specific mutagenesis with Co-IP and knockdown, single lab\",\n      \"pmids\": [\"35484132\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CHIP (carboxyl-terminus of Hsc70-interacting protein, an E3 ubiquitin ligase) promotes proteasomal degradation of NFATc3; co-immunoprecipitation demonstrates physical interaction between CHIP and NFATc3, and CHIP overexpression reduces NFATc3 protein levels and attenuates hypertrophy and apoptosis.\",\n      \"method\": \"Co-immunoprecipitation, Western blot, proteasome inhibitor treatment, CHIP overexpression\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single Co-IP with functional overexpression data, single lab\",\n      \"pmids\": [\"30980393\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NFATc3 transcriptionally upregulates miR-204 in macrophages; miR-204-5p suppresses SR-A expression via canonical 3'UTR targeting, while nuclear miR-204-3p inhibits CD36 transcription; this NFATc3/miR-204 axis prevents foam cell formation and atherosclerosis.\",\n      \"method\": \"Macrophage-specific NFATc3 knockout and transgenic mice, ChIP, miR-204 rescue experiments, luciferase reporter\",\n      \"journal\": \"European heart journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — tissue-specific genetic KO and transgenic mice with ChIP and rescue experiments\",\n      \"pmids\": [\"34570211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NFATc3 activates miR-153-3p expression in cardiomyocytes; ChIP-qPCR and luciferase reporter assay confirmed NFATc3 as upstream transcriptional regulator of miR-153-3p; miR-153-3p suppresses Mfn1 translation, promoting mitochondrial fission and hypertrophy.\",\n      \"method\": \"ChIP-qPCR, luciferase reporter assay, siRNA knockdown, mitochondrial morphology imaging\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assay, single lab\",\n      \"pmids\": [\"31903137\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NFATc3 binds to the promoters of IFNL1 and IFNB1 genes in hepatocytes to promote IFN production; RIG-I pathway activation increases NFATc3 nuclear localization, which further enhances RIG-I-mediated IFN responses (positive feedback).\",\n      \"method\": \"ChIP, reporter gene assay, gain- and loss-of-function experiments, nuclear localization assay\",\n      \"journal\": \"Oncoimmunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with reporter assay and gain/loss of function, single lab\",\n      \"pmids\": [\"33520407\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Trim39 is an E3 ubiquitin ligase for NFATc3 that acts preferentially on SUMOylated forms of NFATc3; Trim39 binds and ubiquitinates NFATc3 in vitro and in cells, reducing NFATc3 protein level and transcriptional activity; Trim17 inhibits Trim39-mediated ubiquitination of NFATc3 by reducing both Trim39 E3 activity and the NFATc3/Trim39 interaction.\",\n      \"method\": \"In vitro ubiquitination assay, co-immunoprecipitation, siRNA knockdown, luciferase reporter, SUMOylation site mutagenesis, SUMO-interacting motif mutagenesis\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro ubiquitination assay plus mutagenesis and Co-IP, replicated with cellular assays\",\n      \"pmids\": [\"35449213\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NFATc3 promotes Ca2+-dependent MMP3 expression in astrocytes; constitutively active NFATc3 induces Mmp3 expression, and a Mmp3 promoter luciferase reporter is activated by increased [Ca2+]i via calcineurin/NFAT, while other MMPs are unaffected.\",\n      \"method\": \"Constitutively active NFATc3 overexpression, calcium ionophore, cyclosporin A inhibition, promoter reporter assay, in vivo stab-wound model\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay with pharmacological and genetic activation, in vivo validation\",\n      \"pmids\": [\"23625833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NFATc3 binds to the -GGAAA- sequence in the COX-2 promoter and transcriptionally activates COX-2 expression in cardiomyocytes in response to endothelin-1, as demonstrated by ChIP and promoter reporter assay.\",\n      \"method\": \"ChIP, promoter reporter assay, NFATc3 knockdown, cyclosporin A\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with reporter assay, single lab\",\n      \"pmids\": [\"24291639\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Nuclear Raf-1 phosphorylated at Ser621 associates with NFATc3 near its cognate binding site in the CXCR5 promoter, driving transcriptional upregulation of CXCR5 during retinoic acid-induced differentiation of HL-60 leukemic cells.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, pharmacological inhibition (PD98059), reporter assay\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and ChIP with functional inhibitor validation, single lab\",\n      \"pmids\": [\"24330068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NFATc3 regulates CXCL2 gene expression in macrophages (CXCL2 promoter-luciferase reporter activity is accentuated by co-transfection with NFATc3 expression vector); NFATc3-deficient macrophages fail to produce CCL2 and CXCL2 in response to IL-33 or conditioned medium from bleomycin-treated epithelial cells, and adoptive transfer of NFATc3+/+ macrophages restores susceptibility to pulmonary fibrosis in NFATc3+/- mice.\",\n      \"method\": \"Promoter-luciferase reporter assay, macrophage-specific conditional KO, adoptive transfer, in vitro cytokine stimulation\",\n      \"journal\": \"Aging and disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay with genetic KO and adoptive transfer, single lab\",\n      \"pmids\": [\"37523510\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NFATc3 occupies the RAG1 promoter for transcriptional repression; NFATc3 knockdown increases RAG1 expression and double-strand DNA damage in gastric cancer cells, while NFATc3 overexpression blocks RAG1 expression and DNA damage induced by arsenic sulfide.\",\n      \"method\": \"ChIP-qPCR, RNA-seq, siRNA knockdown, lentiviral overexpression, Western blot\",\n      \"journal\": \"Journal of experimental & clinical cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with gain and loss of function, single lab\",\n      \"pmids\": [\"31822296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NFATc3 binds to the OCT4 promoter and activates OCT4 transcription to promote cancer stem cell self-renewal in oral squamous cell carcinoma; inhibition of OCT4 abrogates the CSC phenotype driven by NFATc3.\",\n      \"method\": \"ChIP, promoter reporter assay, NFATc3 overexpression and knockdown, OCT4 rescue experiments, tumor sphere formation assay\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with promoter reporter and epistasis rescue, single lab\",\n      \"pmids\": [\"31040921\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NFATc3 promotes myocardin (and AQP2) promoter activity; NFATc3 knockout mice display symptoms of nephrogenic diabetes insipidus (polyuria, reduced AQP2 expression) and ILK-conditional-knockdown mice show reduced nuclear localization of NFATc3, linking ILK→GSK3β→NFATc3 to AQP2 transcription.\",\n      \"method\": \"NFATc3 knockout mice, ILK conditional knockdown, reporter gene assay, nuclear localization assay\",\n      \"journal\": \"Biochimica et biophysica acta. Gene regulatory mechanisms\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with reporter assay, single lab\",\n      \"pmids\": [\"28736155\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NFATc3 interacts with c-JUN and regulates the expression of SRPX2; SRPX2 knockdown diminishes the upregulation of lineage and EMT markers induced by co-overexpression of NFATc3 and c-JUN in human embryonic stem cells, placing SRPX2 downstream of the NFATc3/c-JUN complex.\",\n      \"method\": \"Co-immunoprecipitation (NFATc3/c-JUN), siRNA knockdown, overexpression, differentiation marker assays\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP with siRNA epistasis, single lab\",\n      \"pmids\": [\"33393109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Activity-independent nucleocytoplasmic shuttling of NFATc1 occurs in resting skeletal muscle fibers (leptomycin B causes nuclear accumulation); however, NFATc3 does NOT show similar shuttling in resting fibers — leptomycin B did not cause nuclear accumulation of NFATc3 in unstimulated fibers, demonstrating isoform-specific regulation.\",\n      \"method\": \"Live-cell imaging of GFP-NFAT isoforms in adult skeletal muscle fibers, leptomycin B treatment, electrical stimulation, calcineurin inhibition\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct live imaging with pharmacological tools, negative result for NFATc3 vs positive for NFATc1 clearly demonstrated\",\n      \"pmids\": [\"16436503\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NFATC3 is a calcium-dependent transcription factor that resides in a heavily phosphorylated, cytoplasmic inactive state; calcium signals promote its association with calcineurin, which dephosphorylates key serine residues (initially Ser177 via a CK1α-primed hierarchical mechanism, opposed by JNK-mediated phosphorylation) to unmask the nuclear localization signal, enabling nuclear import as a calcineurin–NFATC3 complex; in the nucleus it binds NFAT/AP-1 composite sites to drive target gene programs including Kv2.1/BK-β1 channel subunit suppression in vascular smooth muscle, miR-23a/miR-153-3p/miR-324-5p-mediated cardiac hypertrophic remodeling, COX-2 and RANKL transactivation, IRF7-dependent type I interferon production in plasmacytoid dendritic cells, and alpha-actin/sGC-α1 upregulation during pulmonary hypertension; its activity is further tuned by SUMOylation (deSUMOylation by SENP3 at K384 reduces GSK-3β-mediated phosphorylation to increase nuclear occupancy under hypoxia), by CHIP/Trim39-mediated ubiquitin-proteasomal degradation (Trim39 preferentially targets SUMOylated NFATc3, antagonized by Trim17), and by PICK1-scaffolded coupling to ASIC1-mediated Ca2+ influx for nuclear import.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NFATC3 is a calcium- and calcineurin-regulated transcription factor that converts intracellular Ca2+ signals into target-gene programs governing cardiovascular remodeling, vascular tone, immune signaling, and cell differentiation [#0, #6, #7]. In its resting state it is held in the cytoplasm by phosphorylation: casein kinase Iα directly binds and phosphorylates the regulatory A domain through a two-phase hierarchical mechanism in which a primed Ser177 nucleates phosphorylation of downstream serines, masking the nuclear localization signal [#2, #19], and JNK phosphorylates additional sites that drive nuclear exclusion [#1]. Calcium influx triggers physical association with the phosphatase calcineurin, which dephosphorylates NFATC3 and is co-transported with it into the nucleus where it counters a nuclear NFAT kinase to sustain nuclear residence [#0]. In the nucleus NFATC3 binds NFAT sites, frequently cooperating with AP-1 partners such as c-Jun, to activate transcription with a DNA-binding specificity distinct from other family members [#3, #4, #49]. Genetic deletion establishes NFATC3 as the obligatory calcineurin effector for pathological cardiac hypertrophy and for arterial smooth-muscle remodeling, where it suppresses K+ channel subunits (Kv1.5, Kv2.1, Kv4.2/4.3) and the BK channel β1 and α subunits to alter excitability and tone during hypertension and after myocardial infarction [#6, #7, #8, #9, #22]. It drives hypoxia-induced pulmonary arterial remodeling and directly transactivates target promoters including sGC-α1, COX-2, RANKL, and myocardin, and activates miRNA programs (miR-23a, miR-153-3p, miR-324-5p, miR-204) that tune hypertrophy, mitochondrial fission, and atherogenesis [#11, #13, #14, #23, #38, #43]. In immunity NFATC3 binds IRF7 and type I interferon promoters to potentiate antiviral interferon production and controls chemokine output in macrophages and during pathogen infection [#31, #33, #40, #45]. Its abundance and nuclear occupancy are further set by SUMOylation, by SENP3-mediated deSUMOylation that weakens GSK-3β-dependent phosphorylation under hypoxia, and by the E3 ligases CHIP and Trim39 that drive proteasomal turnover, with Trim39 acting preferentially on SUMOylated NFATC3 and being antagonized by Trim17 [#36, #37, #41].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Establishing that NFATC3 is a genuine NFAT-family transcription factor required showing it binds NFAT DNA elements and activates transcription in a calcium-regulated manner, which it did with distinct site specificity and AP-1 cooperativity.\",\n      \"evidence\": \"EMSA, reporter assays, and calcium-dependent mobility shift in COS-7/transfected cells\",\n      \"pmids\": [\"7739550\", \"7650004\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous target genes not yet defined\", \"Mechanism of calcium-dependent mass change inferred, not directly mapped to residues\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"The core activation switch was defined by demonstrating calcium-induced physical association with calcineurin and co-transport as a complex that maintains nuclear dephosphorylation against an opposing kinase.\",\n      \"evidence\": \"Co-immunoprecipitation, nuclear import assays, cyclosporin A/FK506 inhibition\",\n      \"pmids\": [\"8684469\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the opposing nuclear kinase not resolved here\", \"Binding interface not mapped\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"The kinase arm opposing activation was identified by showing JNK phosphorylates two sites whose mutation causes constitutive nuclear NFATC3, establishing JNK as an antagonist of calcineurin-driven import.\",\n      \"evidence\": \"In vitro kinase assay, phosphosite mutagenesis, nuclear localization readout\",\n      \"pmids\": [\"9374467\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signals controlling JNK in physiological contexts not addressed\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"How phosphorylation masks the NLS was clarified by showing CKIα directly binds and phosphorylates NFATC3 to enforce cytoplasmic retention, with MEKK1 stabilizing this interaction.\",\n      \"evidence\": \"Co-IP, in vitro kinase assay, nuclear translocation and co-expression epistasis\",\n      \"pmids\": [\"9630228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise serines targeted by CKIα not yet enumerated at this stage\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"The biochemical logic of CKI control was resolved by defining a docking-and-priming hierarchical mechanism initiating at Ser177 and propagating to downstream serines.\",\n      \"evidence\": \"Systematic in vitro kinase assays on 27 peptide variants with phosphoserine/alanine mutagenesis and kinetic analysis\",\n      \"pmids\": [\"11781102\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo occupancy of each site under physiological signaling not quantified\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Physiological relevance of the calcineurin/NFAT axis was established genetically by showing NFATC3/NFATC4 double knockouts die with vascular assembly defects phenocopied by a Ca2+-insensitive calcineurin mutation.\",\n      \"evidence\": \"Double knockout and calcineurin B point-mutant knockin mice, embryological analysis\",\n      \"pmids\": [\"11439183\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"NFATC3-specific versus redundant contribution within the double KO not separated\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Cell-type-specific input requirements were defined by showing PDGF-induced nuclear import in smooth muscle needs Ca2+ entry through voltage-dependent channels plus PDGF-driven modulation, indicating Ca2+ alone is insufficient.\",\n      \"evidence\": \"GFP-NFAT4 imaging with Ca2+/K+ channel and calcineurin pharmacology\",\n      \"pmids\": [\"11278965\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The additional PDGF-dependent step controlling import/export not molecularly identified\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"NFATC3 was shown to be the required calcineurin effector for pathological cardiac hypertrophy across multiple stimuli, distinguishing it from NFATC4.\",\n      \"evidence\": \"Knockout mice in calcineurin-transgene, pressure-overload, and angiotensin II hypertrophy models\",\n      \"pmids\": [\"12370307\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct hypertrophic target genes not yet identified in this study\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"A coherent vascular program emerged from knockout studies showing NFATC3 mediates calcineurin-dependent suppression of Kv and BK channel subunits to control arterial and bladder smooth-muscle excitability and tone.\",\n      \"evidence\": \"NFATC3 knockout mice with patch-clamp electrophysiology, Western blot/RT-PCR, hypertension and contractility models\",\n      \"pmids\": [\"15322114\", \"15087419\", \"17148444\", \"16614306\", \"18579799\", \"18832165\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether channel suppression is via direct promoter binding or indirect intermediates not fully resolved for each target\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"The pulmonary remodeling branch was mechanized by showing NFATC3 is required for hypoxia-induced α-actin and sGC-α1 upregulation, with NFATC3 binding the sGC-α1 promoter, and later linked to ET-1/RhoA-ROK-supported nuclear transport.\",\n      \"evidence\": \"Knockout and NFAT-reporter mice, promoter reporter assays, pharmacology and GFP-NFATc3 imaging in PASMC\",\n      \"pmids\": [\"17403661\", \"19592461\", \"21525433\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct NFAT occupancy of the α-actin promoter not shown\", \"ROK/actin contribution to import is correlative\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Direct transcriptional outputs in heart and other tissues were defined by ChIP/reporter evidence placing myocardin, COX-2, RANKL, and several miRNAs downstream of NFATC3.\",\n      \"evidence\": \"ChIP, promoter reporter assays, siRNA knockdown across cardiomyocyte, osteoblast, and T/endothelial systems\",\n      \"pmids\": [\"20177053\", \"19574461\", \"21642596\", \"21514407\", \"24291639\", \"31903137\", \"26633713\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Most targets validated in single labs\", \"Combinatorial cofactor requirements at each promoter not mapped\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Isoform-specific kinetics were established by showing NFATC3 dephosphorylates and translocates rapidly upon mild Ca2+ signals, unlike NFATC4, with its serine-proline region controlling nuclear accumulation magnitude.\",\n      \"evidence\": \"GFP-NFAT chimera imaging, domain-swap constructs, siRNA, reporter assays in neurons; leptomycin B comparison in muscle fibers\",\n      \"pmids\": [\"22977251\", \"16436503\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis for the serine-proline region effect not solved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"An immune signaling role was defined by showing pathogen GRA6/CAMLG selectively activates NFATC3 and that NFATC3 binds IRF7 and type I IFN promoters to potentiate interferon production.\",\n      \"evidence\": \"Knockout parasites and host mice, Co-IP, ChIP, promoter mutagenesis\",\n      \"pmids\": [\"25225460\", \"27697837\", \"33520407\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of the NFATC3-IRF7 complex on promoters not defined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Post-translational control of NFATC3 stability and nuclear occupancy was uncovered through SUMOylation-coupled ubiquitination: Trim17 and Trim39 act on SUMOylated NFATC3, CHIP drives proteasomal turnover, and SENP3 deSUMOylation reduces GSK-3β-dependent phosphorylation under hypoxia.\",\n      \"evidence\": \"Co-IP, in vitro ubiquitination, SUMO/SIM mutagenesis, SENP3 knockdown, ChIP and reporter assays\",\n      \"pmids\": [\"25215946\", \"35449213\", \"30980393\", \"35484132\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Some interactions (e.g., CHIP) rest on single Co-IP\", \"Crosstalk between SUMO, ubiquitin and phosphorylation not integrated quantitatively\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Developmental and oncogenic transcriptional targets were extended by ChIP-based identification of Etv2, OCT4, RAG1, and SRPX2 as NFATC3-regulated loci controlling hematopoietic commitment, stemness, DNA damage, and differentiation.\",\n      \"evidence\": \"ChIP, promoter reporters, genetic rescue, gain/loss-of-function in stem cells and cancer lines\",\n      \"pmids\": [\"28419336\", \"31040921\", \"31822296\", \"33393109\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Each target validated in a single cellular context\", \"Direct repression versus activation mechanisms not uniformly defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"A scaffolded route for Ca2+ entry was defined by showing PICK1 couples ASIC1-mediated Ca2+ influx to calcineurin to drive NFATC3 nuclear import in pulmonary smooth muscle.\",\n      \"evidence\": \"ASIC1 knockout mice, PICK1 inhibition, proximity ligation assay, GFP-NFATc3 imaging\",\n      \"pmids\": [\"27190058\", \"31903118\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PICK1-ASIC1-calcineurin coupling operates outside vascular/synovial contexts unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the multiple post-translational inputs (CKIα/JNK/GSK-3β phosphorylation, SUMOylation, SENP3 deSUMOylation, CHIP/Trim39 ubiquitination) are integrated in real time to set NFATC3 nuclear occupancy and select among its many target programs remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No integrated kinetic model linking modifications to target-gene selection\", \"No structural model of the calcineurin-NFATC3 or NFATC3-IRF7/c-Jun complexes\", \"Tissue determinants of target-gene choice not defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 3, 4, 33, 38, 43]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [3, 4, 23, 43, 35]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 1, 2, 16, 27]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 2, 16]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 2, 18, 21]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [3, 33, 38, 43]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [25, 31, 33, 40, 45]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [36, 37, 41]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"PPP3 (calcineurin)\", \"CSNK1A1\", \"JNK\", \"IRF7\", \"JUN\", \"TRIM39\", \"TRIM17\", \"PICK1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}